---
title: 'Medicine 🍊⭐'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of clinical medicine.

{% include toc %}

# Cardiology / 循環器科

## Introduction / 総論

## Arrhythmia / 不整脈

## Ischemic Heart Disease / 虚血性心疾患

## Valvular Heart Disease / 心臓弁膜症

## Endocardium, Myocardium and Pericardium Disease / 心内膜・心筋・心膜疾患

## Congenital Heart Disease / 先天性心疾患

## Heart Failure / 心不全

## Arterial Disorder / 動脈疾患

## Venous Disorder / 静脈疾患

## Blood Pressure Disorder / 血圧異常

<!-- ## Introduction / 総論

### Cardiovascular Drugs / 循環器疾患治療薬

* **Calcium channel blocker (DHP)**
  * **Drugs**: Amlodipine, nifedipine
  * **Mechanism**: Decrease intracellular calcium, relax smooth muscle
  * **Indication**: Hypertension, angina pectoris
  * **Adverse effect**: Tachycardia, flush
* **Calcium channel blocker (non-DHP)**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Decrease intracellular calcium, inhibit SA node and AV node
  * **Indication**: Supraventribular tachycardia
  * **Adverse effect**: Bradycardia
* **β blockers**
* **αβ blockers**
{: .notice--info}


### Adrenergic Agonist / アドレナリン作動薬

* **αβ agonist**
  * **Drugs**: Epinephrine, norepinephrine, dopamine
  * **Mechanism**: αβ agonist (epinephrine: β>α, norepinephrine: α>β, dopamine: D>β>α)
  * **Indication**: Shock (dopamine preserve renal blood flow), glaucoma (epinephrine)
* **α1 agonist**
  * **Drugs**: Oxymetazoline, phenylephrine, midodrine
  * **Mechanism**: α1 agonist
  * **Indication**: Nasal congestion (Oxymetazoline, phenylephrine), midodrine (orthostatic hypotension)
* **α2 agonist**
  * **Drugs**: Clonidine, methyldopa, brimonidine
  * **Mechanism**: α2 agonist
  * **Indication**: Hypertension (methyldopa: for pregnant women), glaucoma (brimonidine)
* **β agonist**
  * **Drugs**: Isoproterenol
  * **Mechanism**: β1-β2 agonist
  * **Indication**: Bradycardia
* **β1 agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: β1 agonist
  * **Indication**: Heart failure
* **β2 agonist**
  * **Drugs**: Albuterol (salbutamol), terbutaline, fenoterol, metaproterol, procaterol, salmeterol, formoterol, ritodrine
  * **Mechanism**: β2 agonist
  * **Indication**: Asthma, COPD, tocolytic (ritodrine)
* **β3 agonist**
  * **Drugs**: Mirabegron
  * **Mechanism**: β3 agonist
  * **Indication**: Overactive bladder
* **Indirect agonist**
  * **Drugs**: Amphetamine, methylphenidate, modafinil, cocaine, amitryptiline
  * **Mechanism**: Increase catecholamine release (amphetamine), inhibit catecholamine reuptake (others)
  * **Indication**: ADHD, narcolepsy
* **Mixed agonist**
  * **Drugs**: Ephedrine, pseudoephedrine
  * **Mechanism**: Direct and indirect agonist
  * **Indication**: Nasal congestion, nocturnal neuresis
{: .notice--info}

### Adrenergic Antagonist / アドレナリン拮抗薬

* **α antagonist**
  * **Drugs**: Phentolamine, phenoxybenzamine
  * **Mechanism**: Non-selective α antagonist
  * **Indication**: Pheochromocytoma diagnosis (Phentolamine), pheochromocytoma treatment (phenoxybenzamine)
* **α1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin, tamsulosin, indoramin, urapidil
  * **Mechanism**: α1 antagonist
  * **Indication**: Hypertension, BPH
* **α2 antagonist**
  * **Drugs**: Mirtazapine
  * **Mechanism**: α2 antagonist
  * **Indication**: Depression
* **β antagonist**
  * **Drugs**: Nadolol, pindolol, propranolol, timolol
  * **Mechanism**: Non-selective β antagonist
  * **Indication**: Hypertension, arrhythmia, heart failure, glaucoma (timolol)
* **β1 antagonist**
  * **Drugs**: Acebutolol, atenolol, betaxolol, bisoprolol, esmolol, metoprolol
  * **Mechanism**: β1 antagonist
  * **Indication**: Same as β antagonist
* **αβ antagonist**
  * **Drugs**: Labetalol, carvedilol
  * **Mechanism**: αβ antagonist
  * **Indication**: Hypertension, heart failure
* **Indirect antagonist**
  * **Drugs**: Reserpine, guanethidene, bretylium, metyrosine
  * **Mechanism**: Deplete neurotransmitter in vesicle (reserpine), inhibit vesicle release (guanethidine, bretylium), inhibit tyrosine hydroxylase (metyrosine)
  * **Indication**: Hypertension, heart failure
{: .notice--info}

### Cholinergic Agonist / コリン作動薬

* **Direct agonist**
  * **Drugs**: Acetylcholine, bethanechol, carbachol, methacholine, pilocarpine, cevimeline
  * **Mechanism**: Muscarinic agonist (+ nicotinic agonist: acetylcholine, carbachol)
  * **Indication**: Ileus and urinary retension, asthma diagnosis (methacholine), glaucoma (pilocarpine), Sjogren syndrome (cevimeline)
* **Indirect agonist (anti-cholinesterase)**
  * **Drugs**: Physostigmine, neostigmine, pyridostigmine, edrophonium, ambenonium
  * **Mechanism**: Inhibit cholinesterase to increase acetylcholine
  * **Indication**: Myasthenia gravis, ileus and urinary retension, glaucoma (physostigmine)
  * **Organic phosphate**: Irreversible anti-cholinesterase (treatment: pyridostigmine, atropine, pralidoxime)
{: .notice--info}

### Cholinergic Antagonist / コリン拮抗薬

* **Muscarinic antagonist**
  * **Drugs and indication**
    * Reduce exocrine: Atropine
    * Ophthalmoscopic examination: Homatropine, cyclopentolate, tropicamide
    * Motion sickness: Scopolamine
    * Gastric ulcer: Pirenzepine, propantheline
    * Diarrhea and IBS: Dicyclomine, clidinium
    * Asthama and COPD: Ipratropium, tiotropium
    * Overactive bladder: Oxybutynin
    * Parkinson disease: Trihexyphenidyl, bentropine, biperidin
  * **Mechanism**: Muscarinic antagonist
* **Nitotinic antagonist (ganglion blocker)**
  * **Drugs**: Mecamylamine, trimethaphan, hexamethonium
  * **Mechanism**: Nitotinic antagonist at autonomic ganglion
  * **Indication**: Hypertension
* **Nitotinic antagonist (muscle relaxant)**
  * **Drugs**: Tubocurarine, mivacurium, atracurium, cisatracurium, pancuronium, vecuronium, rocuronium, succinylcholine, decamothonium
  * **Mechanism**: Nitotinic antagonist at neuromuscular junction (non-depolarizing: tubocurarine ~ rocuronium, depolarizing: succinylcholine, decamothonium)
  * **Indication**: Anesthesia
* **Other muscle relaxant**
  * **Drugs**: Diazepam, baclofen, tizanidine, dantroline, hemicholinium, botulinum toxin, tetrodotoxin
  * **Mechanism**: GABA-A agonist (diazepam), GABA-B agonist (baclofen), α2 agonist (tizanidine), ryodine receptor blocker (dantroline), inhibit cholien uptake (hemicholinium), inhibit vesicle release (botulinum toxin), inhibit Na+ channel (tetrodotoxin)
  * **Indication**: Spasmolytic
{: .notice--info}

### Antihypertensive Drug / 降圧薬

* **ACE inhibitor**
  * **Drugs**: Captopril, enalapril, lisinopril
  * **Mechanism**: Angiotensin converting enzyme inhibitor
  * **Indication**: Hypertension (heart failure, diabetes)
  * **Adverse effect**: Nonproductive cough, angioadema
* **Angiotensin II receptor blocker**
  * **Drugs**: Losartan, valsartan, candesartan
  * **Mechanism**: Angiotensin II receptor blocker
  * **Indication**: Hypertension
* **Renin inhibitor**
  * **Drugs**: Aliskiren
  * **Mechanism**: Renin inhibitor
  * **Indication**: Hypertension
* **β-blocker**
  * **Drugs**: Acebutolol, atenolol, carvedilol, esmolol, labetalol, metoprolol, pindolol, propranolol
  * **Mechanism**: β1-blocker (reduce cardial output, inhibit renin secretion)
  * **Indication**: Hypertension
  * **Adverse effect**: Asthma
* **Calcium channel blocker**
  * **Drugs**: DHP: Amlodipine, nifedipine, felodipine / Non-DHP: verapamil, diltiazem, bepridil
  * **Mechanism**: Calcium channel blocker (vessel: DHP, heart: non-DHP)
  * **Indication**: Hypertension
* **Vasodilator**
  * **Drugs**: Minoxidil, diazoxide, hydralazine, nitroprusside
  * **Mechanism**: Activate K channel (minoxidil, diazoxide), increase cGMP (hydralazine, nitroprusside)
  * **Indication**: Hypertension
  * **Adverse effect**: Hirsutism (minoxidil), hyperglycemia (diazoxide), lupus-like syndrome (hydralazine), nitroprusside (cyanide toxicity)
* **α1 antagonist**
  * **Drugs**: Prazosin, doxazosin, terazosin
  * **Mechanism**: α1 antagonist 
  * **Indication**: Hypertension (with BPH)
* **α2 agonist**
  * **Drugs**: Clonidine, methyldopa
  * **Mechanism**: α2 agonist 
  * **Indication**: Hypertension (pregnancy)
* **D1 agonist**
  * **Drugs**: Fenoldopam
  * **Mechanism**: D1 agonist
  * **Indication**: Malignant hypertension
* **PDE5 inhibitor**
  * **Drugs**: Sildenafil, vardenafil
  * **Mechanism**: PDE5 inhibitor, increase cGMP
  * **Indication**: Pulmonary hypertension, erectile dysfunction
* **Diuretics**
  * See diuretics
{: .notice--info}

### Heart Failure Drug / 心不全の薬

* **Cardiac glycoside**
  * **Drugs**: Digoxin, digitoxin
  * **Mechanism**: Inhibit Na/K ATPase, elevate intreacellular Ca
  * **Indication**: Congestive heart failure
  * **Adverse effect**: GI distress, visual disturbance, digoxin toxicity (treat with potassium and antibody)
* **PDE3 inhibitor**
  * **Drugs**: Melrinone, amrinone
  * **Mechanism**: Inhibit PDE3, increase cAMP
  * **Indication**: Heart failure
* **Adrenergic agonist**
  * **Drugs**: Dobutamine
  * **Mechanism**: β1 agonist
  * **Indication**: Heart failure
* **BNP agonist**
  * **Drugs**: Nesiritide, sacubitril
  * **Mechanism**: BNP agonist (nersiritide), increase BNP (sacubitril)
  * **Indication**: Heart failure
{: .notice--info}

### Antianginal Drug / 抗狭心症薬

* **Nitrates**
  * **Drugs**: Nitroglycerin, isosorbide mononitrate, isosorbide dinitrate
  * **Mechanism**: Increase cGMP
  * **Indication**: Angina pectoris
  * **Adverse effect**: Headache, flushing
* **Ranolazine**
  * **Drugs**: Ranolazine
  * **Mechanism**: Inhibit Na current, decrease intracellular Ca
  * **Indication**: Angina pectoris
  * **Adverse effect**: QT prolongation
{: .notice--info}

### Antiarrhythmic Drug / 抗不整脈薬

* **Class IA**
  * **Drugs**: Quinidine, procainamide, disopyramide
  * **Mechanism**: Na (and K) channel blocker (prolong QRS)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, cinchonism (quinidine), lupus-like syndrome (procainamide)
* **Class IB**
  * **Drugs**: Mexiletine, lidocaine, phenytoin
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class IC**
  * **Drugs**: Flecanide, propafenone
  * **Mechanism**: Na channel blocker (prolong QRS)
  * **Indication**: Arrythmia
* **Class II**
  * **Drugs**: Propranolol, metoprolol, pindolol, esmolol
  * **Mechanism**: β blocker (prolong PR)
  * **Indication**: Tachycardia, Post-MI
* **Class III**
  * **Drugs**: Amiodarone, dronedarone, sotalol, ibutilide, dofetilide
  * **Mechanism**: K channel blocker (prolong QT)
  * **Indication**: Arrythmia
  * **Adverse effect**: Torsade de pointes, thyroid dysfunction (amiodarone), liver dysfunction (amiodarone), pulmonary fibrosis (amiodarone)
* **Class IV**
  * **Drugs**: Verapamil, diltiazem, bepridil
  * **Mechanism**: Ca channel blocker (prolong PR)
  * **Indication**: Tachycardia
* **Class V**
  * **Drugs**: Adenosine, MgSO4
  * **Mechanism**: Gi (adenosine)
  * **Indication**: PSVT (adenosine), torsade de pointes (MgSO4)
{: .notice--info} -->

<!-- ## Heart Failure / 心不全

### Left-Sided Heart Failure / 左心不全
### Right-Sided Heart Failure / 右心不全

## Arrhythmia / 不整脈

### Sinus Tachycardia / 洞性頻脈
### Paroxysmal Supraventricular Tachycardia / 発作性上室頻拍
### Wolff-Parkinson-White Syndrome / WPW症候群
### Atrial Flutter / 心房粗動
### Atrial Fibrillation / 心房細動
### Atrial Premature Contraction / 心房期外収縮
### Ventricular Premature Contraction / 心室期外収縮
### Ventricular Tachycardia / 心室頻拍
### Ventricular Fibrillation / 心室細動
### Long QT Syndrome / QT延長症候群
### Brugada Syndrome / Brugada症候群
### Sick Sinus Syndrome / 洞不全症候群
### Atrioventricular Block / 房室ブロック
### Bundle Branch Block / 脚ブロック

## Ischemic Heart Disease / 虚血性心疾患

### Effort Angina Pectoris / 労作性狭心症
### Vasospastic Angina Pectoris / 冠攣縮性狭心症
### Unstable Angina Pectoris / 不安定狭心症
### Acute Myocardial Infarction / 急性心筋梗塞
### Complication of Myocardial Infarction / 心筋梗塞の合併症

## Valvular Heart Disease / 心臓弁膜症

### Mitral Stenosis / 僧帽弁狭窄症
### Mitral Regurgitation / 僧帽弁閉鎖不全症
### Mitral Valve Prolapse / 僧帽弁逸脱症
### Aortic Stenosis / 大動脈弁狭窄症
### Aortic Regurgitation / 大動脈弁閉鎖不全症
### Tricuspid Stenosis / 三尖弁狭窄症
### Tricuspid Regurgitation / 三尖弁閉鎖不全症

## Endocardium, Myocardium and Pericardium Disease / 心内膜・心筋・心膜疾患

### Infectious Endocarditis / 感染性心内膜炎
### Cardiac Myxoma / 心臓粘液腫
### Dilated Cardiomyopathy / 拡張型心筋症
### Hypertrophic Cardiomyopathy / 肥大型心筋症
### Restrictive Cardiomyopathy / 拘束型心筋症
### Takotsubo-Type Cardiomyopathy / たこつぼ型心筋症
### Myocarditis / 心筋炎
### Acute Pericarditis / 急性心膜炎
### Cardiac Tamponade / 心タンポナーデ
### Constrictive Pericarditis / 収縮性心膜炎

## Arterial Disease / 動脈疾患

### Arteriosclerosis / 動脈硬化
### Aortic Aneurysm / 大動脈瘤
### Aortic Dissection / 大動脈解離
### Arterio-Venous Fistula / 動静脈瘻
### Acute Arterial Occlusive Disease / 急性動脈閉塞症
### Arteriosclerosis Obliterans / 閉塞性動脈硬化症
### Thromboangiitis Obliterans / 閉塞性血栓血管炎
### Raynaud Disease / Raynaud病

## Venous Disease / 静脈疾患

### Deep Vein Thrombosis / 深部静脈血栓症
### Varicose Vein / 下肢静脈瘤
### SVC Syndrome / 上大静脈症候群
### Lymphedema / リンパ浮腫

## Blood Pressure Disorder / 血圧異常

### Essential Hypertension / 本態性高血圧症
### Secondary Hypertension / 二次性高血圧症
### Malignant Hypertension / 悪性高血圧症
### Hypotension / 低血圧 -->

# Pulmonology/ 呼吸器科

## Introduction / 総論

## Infectious Disorder / 感染性疾患

## Immune and Allergic Disorder / 免疫・アレルギー性疾患

## Interstitial Lung Disease / 間質性肺疾患

## Obstructive Lung Disease / 閉塞性肺疾患

## Lung Tumor / 肺腫瘍

## Pulmonary Circulation Disorder / 肺循環障害

## Functional Respiratory Disorder / 機能的呼吸障害

## Pleural Disorder / 胸膜疾患

## Mediastinal Disorder / 縦隔疾患

## Miscellaneous Respiratory Disorder / その他の呼吸器疾患

<!-- ### Inferior Respiratory Tract / 下気道

* **Bronchial tree**
  * **Structure**: Trachea, main bronchus, lobar bronchus, segmental bronchus, terminal bronchus (conduction) \| (respiratory) respiratory bronchus, alveolar duct, alveolus
  * **Trachea and broncus**: Smooth muscle, cartilage, gland, globet cell, pseudostratified columnar
  * **Bronchiole**: Smooth muscle, simple columnar to cuboid, Clara cell (surfactant)
  * **Alveoli**: Simple squamous, type I pneumocyte (septum), type II pneumocyte (surfactant), alveolar macrophate
* **Lung**
  * **Structure**: 2 left lobe (9 segment), 3 right lobe (10 segment), horizontal fissure, oblique fissure
  * **Root**: Main bronchus, pulmonary artery and vein, bronchiolar artery and vein, phrenic nerve (anterior), vagus nerve (posterior)
  * **Hilum**: Left (heart, aortic arch, thoracic aorta, aorta-bronchus-vein), right (vena cava, azygos vein, bronchus-aorta-vein)
  * **Artery**: Pulmonary artery (exchange), bronchial artery (nutrition)
  * **Nerve**: Sympathetic nerve (bronchodilation, vasoconstriction), Parasympathetic nerve (bronchoconstriction, vasodilation, sensation)
  * **Pleura**: Visceral pleura (autonomic nerve), parietal pleura (intercostal nerve, phrenic nerve), pleural cavity
  * **Inferior**: Lung (R6-R8-R10), pleura (R8-R10-R12)
{: .notice--info} -->

<!-- ## Infectious Disease / 感染性疾患

### Acute Bronchiolitis / 急性細気管支炎
### Community-Acquired Pneumonia / 市中肺炎
### Hospital-Acquired Pneumonia / 院内肺炎
### Aspiration Pneumonia / 誤嚥性肺炎
### Streptococcus Penumoniae Pneumonia / 肺炎球菌肺炎
### Haemophilus Influenzae Pneumonia / インフルエンザ菌肺炎
### Klebsiella Pneumoniae Pneumonia / クレブシエラ肺炎
### Staphylococcus Aureus Pneumonia / 黄色ブドウ球菌肺炎
### Moraxella Catarrhalis Pneumonia / モラクセラ肺炎
### Pseudomonas Aeruginosa Pneumonia / 緑膿菌肺炎
### Legionella Pneumophila Pneumonia / レジオネラ肺炎
### Mycoplasma Pneumoniae Pneumonia / マイコプラズマ肺炎
### Chlamydophila Pneumoniae Pneumonia / クラミジア肺炎
### Psittacosis / オウム病
### Viral Pneumonia / ウイルス性肺炎
### Lung Abscess / 肺膿瘍
### Pulmonary Tuberculosis / 肺結核
### Miliary Tuberculosis / 粟粒結核
### Nontuberculous Mycobacteriosis / 非結核性抗酸菌症
### Simple Pulmonary Aspergilloma / 単純性肺アスペルギローマ
### Chronic Progressive Pulmonary Aspergillosis / 慢性進行性肺アスペルギルス症
### Invasive Pulmonary Aspergillosis / 侵襲性肺アスペルギルス症
### Pulmonary Cryptococcosis / 肺クリプトコッカス症

## Obstructive Lung Disease / 閉塞性肺疾患

### Chronic Obstructive Pulmonary Disease / 慢性閉塞性肺疾患
### Diffuse Panbronchiolitis / びまん性汎細気管支炎
### Lymphangioleiomyomatosis / リンパ脈管筋腫症

## Interstitial Lung Disease / 間質性肺疾患

### Idiopathic Pulmonary Fibrosis / 特発性肺線維症
### Non-Specific Interstitial Pneumonia / 非特異性間質性肺炎
### Cryptogenic Organizing Pneumonia / 特発性器質化肺炎
### Asbestosis / 石綿肺
### Silicosis / 珪肺
### Radiation Pneumonitis / 放射線肺炎
### Drug-Induced Pneumonia / 薬剤性肺炎

## Immune and Allergic Lung Disease / 免疫・アレルギー性肺疾患

### Bronchial Asthma / 気管支喘息
### Aspirin-Induced Asthma / アスピリン喘息
### Acute Eosinophilic Pneumonia / 急性好酸球性肺炎
### Chronic Eosinophilic Pneumonia / 慢性好酸球性肺炎
### Allergic Bronchopulmonary Aspergillosis / アレルギー性気管支肺アスペルギルス症
### Hypersensitivity Pneumonitis / 過敏性肺炎

## Lung and Bronchus Malformation / 肺・気管支の形態異常
### Bronchiectasis / 気管支拡張症
### Atelectasis / 無気肺
### Pulmonary Sequestration / 肺分画症
### Pulmonary Cystic Disease / 肺嚢胞症
### Pulmonary Alveolar Proteinosis / 肺胞蛋白症

## Lung Tumor / 肺腫瘍

### Pulmonary Hamartoma / 肺過誤腫
### Squamous Cell Carcinoma / 扁平上皮癌
### Adenocarcinoma / 腺癌
### Small Cell Lung Carcinoma / 小細胞肺癌
### Metastatic Lung Tumor / 転移性肺腫瘍

## Pulmonary Circulation Disorder / 肺循環障害

### Pulmonary Thromboembolism / 肺血栓塞栓症
### Idiopathic Pulmonary Arterial Hypertension / 特発性肺動脈性肺高血圧症
### Cor Pulmonale / 肺性心
### Pulmonary Arteriovenous Fistula / 肺動静脈瘻
### Pulmonary Edema / 肺水腫
### Acute Respiratory Distress Syndrome / 急性呼吸窮迫症候群

## Functional Respiratory Disease / 機能的呼吸障害

### Hyperventilation Syndrome / 過換気症候群
### CO2 Narcosis / CO2ナルコーシス
### Sleep Apnea Syndrome / 睡眠時無呼吸症候群

## Pleural Disease / 胸膜疾患

### Pneumothorax / 気胸
### Pleuritis / 胸膜炎
### Pyothorax / 膿胸
### Chylothorax / 乳び胸
### Pleural Mesothelioma / 胸膜中皮腫

## Mediastinal Disease / 縦隔疾患

### Acute Mediastinitis / 急性縦隔炎
### Mediastinal Emphysema / 縦隔気腫
### Thymoma / 胸腺腫
### Neurogenic Tumor / 神経原性腫瘍
### Germ Cell Tumor / 胚細胞腫瘍 -->

# Gastroenterology / 消化器科

## Introduction / 総論

## Esophagus Disorder / 食道疾患

## Stomach Disorder / 胃疾患

## Intestine Disorder / 腸疾患

## Anus Disorder / 肛門疾患

## Peritoneum Disorder / 腹膜疾患

## Liver Disorder / 肝疾患

## Biliary Tract Disorder / 胆道疾患

### Cholelithiasis / 胆石症

* **Overview**
  * Stones in gallbladder, bile duct or liver
  * Commonly in middle-aged and older adults
* **Presentation**
  * **Asymptomatic**
  * **Sudden pain in right upper quadrant, lasting for hours**: Gallstone temporarily obstructs cystic or bile duct, leading to increased pressure in gallbladder
  * **Radiating pain to right shoulder or back**: Irritation of phrenic nerve
  * **Nausea, vomiting**: Irritation of vagus nerve
* **Examination**
  * **[Blood] ALP↑, γ-GT↑, bilirubin↑**: Bile stasis and bile duct damage
  * **[Ultrasound] High-echoic image with acoustic shodows**: Stone reflects sound waves
  * **[CT] High-density stone**
  * **[MRCP, ERCP] Defect images of stone**
* **Management**
  * **NSAIDs, anticholinergic drugs**: Relieve pain
  * **[Gallbladder stone] Observation (asymptomatic), laparoscopic cholecystectomy (symptomatic)**: Remove gallbladder and stones
  * **[Common bile duct stone] Endoscopic sphincterotomy or endoscopic papillary balloon dilation, endoscopic lithotripsy**: Widen sphincter of Oddi and remove stones
  * **[Intrahepatic stone] Percutaneous transhepatic cholangioscopy, hepatectomy (liver atrophy or intrahepatic cholangiocarcinoma)**: Remove stones, remove liver lobe if necessary
{: .notice--info}

### Acute Cholecystitis / 急性胆嚢炎

* **Overview**
  * Acute inflammation and infection of gallbladder, due to blockage of cystic duct by stones
  * Commonly in middle-aged and older adults, with history of gallstones
* **Presentation**
  * **Pain in right upper quadrant, Murphy's sign**: Increased pressure and inflammation of gallbladder
  * **Fever**: Infection
  * **Abdominal tenderness, muscle guarding**: Irritation of peritoneum
* **Examination**
  * **[Blood] WBC↑, CRP↑**: Infection
  * **[Blood] ALP↑, γ-GT↑, bilirubin↑**: Bile stasis and bile duct damage
  * **[Ultrasound, CT] Gallbladder wall thickening, gallbladder enlargement, debris, gallstones**: Inflammation and bile stasis
* **Management**
  * **[Initial treatment] Fasting, IV fluids, antibiotics (IV), analgesics**: For infection and pain
  * **[Unstable state] Percutaneous transhepatic gallbladder drainage**: Reduce gallbladder pressure and infection
  * **[Stable state] Laparoscopic cholecystectomy**: Remove gallbladder
{: .notice--info}

### Acute Cholangitis / 急性胆管炎

* **Overview**
  * Acute inflammation and infection of bile duct, due to blockage of common bile duct by stones or tumor, may progress to sepsis if endotoxin enters bloodstream through liver retrogradely
  * Commonly in middle-aged and older adults, with history of gallstones
* **Presentation**
  * **Abdominal pain**: Increased pressure and inflammation of biliary system
  * **Fever (with chills)**: Infection
  * **Jaundice**: Obstruction of bile duct
  * **Shock, altered consciousness**: Sepsis leads to drop in BP
* **Examination**
  * **[Blood] WBC↑, CRP↑**: Infection
  * **[Blood] ALP↑, γ-GT↑, bilirubin↑**: Bile stasis and bile duct damage
  * **[Blood] AST↑, ALT↑**: Liver damage
  * **[Ultrasound, CT] Dilated bile ducts, gallstones**: Obstruction of bile flow
* **Management**
  * **[Initial treatment] Fasting, IV fluids, antibiotics (IV), analgesics**: For infection and pain
  * **[Unstable state] Endoscopic biliary drainage or percutaneous transhepatic biliary drainage**: Reduce biliary tract pressure and infection
  * **[Stable state] Endoscopic sphincterotomy or endoscopic papillary balloon dilation, endoscopic lithotripsy**: Remove stones
{: .notice--info}

### Primary Biliary Cholangitis / 原発性硬化性胆管炎

* **Overview**
  * Chronic inflammation of intraphepatic and extrahepatic biles ducts, leading to fibrous thickening of bile ducts and eventually liver cirrhosis
  * Bimodal peaks in 20s and 60s, more in men, associated with ulcerative colitis
* **Presentation**
  * **Asymptomatic**
  * **Fluctuating jaundice and puritis**: Bile stasis leads to bilirubin and bile acids accumulation
* **Examination**
  * **[Blood] ALP↑, γ-GT↑, bilirubin↑**: Bile stasis and bile duct damage
  * **[Blood] AST↑, ALT↑ (slightly)**: Liver damage
  * **[Blood] P-ANCA(+)**: Autoimmune nature
  * **[ERCP, MRCP] Multiple strictures and irregularities of intrehepatic and extrahepatic bile ducts**: Narrowing due to fibrosis, dilatation due to obstruction
* **Management**
  * **UDCA, bezafibrate**: Improve bile flow
  * **Cholestyramine, antihistamine**: Relieve puritis
  * **Biliary drainage**: Relieve jaundice
  * **Liver transplantation**: Only treatment for advanced cases
{: .notice--info}

### Congenital Biliary Dilatation / 先天性胆道拡張症

* **Overview**
  * Congenital dilatation of extrahepatic bile ducts, often accompanied by abnormal pancreaticobiliary junction, with high incidence of biliary tract carcinoma
  * Commonly in younger individuals, more in females and Asians
* **Presentation**
  * **Asymptomatic**
  * **Abdominal pain**: Inflammation caused by pancreatic enzyme reflux
  * **Jaundice**: Bile stasis
  * **Abdominal mass**: Dilated bile ducts
* **Examination**
  * **[Blood] ALP↑, γ-GT↑**: Bile duct damage
  * **[Blood] Amylase↑**: Pancreatic enzyme reflux to bile ducts
  * **[Ultrasound, CT] Dilated common bile duct**
  * **[MRCP, ERCP] Cystic or fusiform dilatation of common bile duct, abnormal junction of pancreatic duct and common bile duct outside duodenal wall**
* **Management**
  * **Extrahepatic duct resection, cholecystectomy, biliary reconstruction**: Prevent biliary tract carcinoma
{: .notice--info}

## Pancreas Disorder / 膵疾患

<!-- 
## Esophageal Disease / 食道疾患

### Achalasia / 食道アカラシア
### Gastroesophageal Reflux Disease / 胃食道逆流症
### Eosinophilic Esophagitis / 好酸球性食道炎
### Esophageal Candidiasis / 食道カンジダ症
### Mallory-Weiss Syndrome / Mallory-Weiss症候群
### Spontaneous Rupture of the Esophagus / 特発性食道破裂
### Esophageal Cancer / 食道癌
### Esophagogastric Varices / 食道・胃静脈瘤
### Esophageal Diverticulum / 食道憩室

## Gastric and Duodenal Disease / 胃・十二指腸疾患

### Acute Gastric Mucosal Lesion / 急性胃粘膜病変
### Chronic Gastritis / 慢性胃炎
### Functional Dyspepsia / 機能性ディスペプシア
### Gastro-Duodenal Ulcer / 胃・十二指腸潰瘍
### Gastro-Duodenal Ulcer Perforation / 胃・十二指腸潰瘍穿孔
### Gastric Polyp / 胃ポリープ
### GIST / 消化管間質腫瘍
### Gastrointestinal Malignant Lymphoma / 消化管悪性リンパ腫
### Gastric Cancer / 胃癌
### Dumping Syndrome / ダンピング症候群
### Gastro-Duodenal Diverticulum / 胃・十二指腸憩室
### Superior Mesenteric Artery Syndrome / 上腸間膜動脈症候群
### Ménétrier's Disease / Ménétrier病

## Intestinal and Colonic Disease / 小腸・大腸疾患

### Crohn's Disease / Crohn病
### Ulcerative Colitis / 潰瘍性大腸炎
### Intestinal Tuberculosis / 腸結核
### Infectious Enterocolitis / 感染性腸炎
### Pseudomembranous Colitis / 偽膜性大腸炎
### Antibiotic-Associated Hemorrhagic Colitis / 抗菌薬関連出血性大腸炎
### MRSA Enteritis / MRSA腸炎
### Irritable Bowel Syndrome / 過敏性腸症候群
### Colonic Polyp / 大腸ポリープ
### Colorectal Cancer / 大腸癌
### Lynch Syndrome / Lynch症候群
### Small Intestine Tumor / 小腸腫瘍
### Gastrointestinal Neuroendocrine Neoplasm / 消化管神経内分泌腫瘍
### Familial Adenomatous Polyposis / 家族性腺腫性ポリポーシス
### Peutz-Jeghers Syndrome / Peutz-Jeghers症候群
### Malabsorption Syndrome / 吸収不良症候群
### Protein-Losing Gastroenteropathy / 蛋白漏出性胃腸症
### Ischemic Colitis / 虚血性大腸炎
### Acute Mesenteric Artery Occlusion / 急性腸間膜動脈閉塞症
### Occlusive Ileus / 閉塞性腸閉塞
### Strangulation Ileus / 絞扼性腸閉塞
### Paralytic Ileus / 麻痺性イレウス
### Colonic Diverticulum / 大腸憩室
### Acute Appendicitis / 急性虫垂炎

## Anal Disease / 肛門疾患

### Hemorrhoids / 痔核
### Anal Fissure / 裂肛
### Perianal Abscess / 肛門周囲膿瘍
### Anal Fistula / 痔瘻
### Rectal Prolapse / 直腸脱

## Peritoneal Disease / 腹膜疾患

### Inguinal Hernia / 鼠径ヘルニア
### Femoral Hernia / 大腿ヘルニア
### Obturator Hernia / 閉鎖孔ヘルニア
### Abdominal Incisional Hernia / 腹壁瘢痕ヘルニア
### Umbilical Hernia / 臍ヘルニア
### Esophageal Hiatal Hernia / 食道裂孔ヘルニア
### Acute Peritonitis / 急性腹膜炎
### Spontaneous Bacterial Peritonitis / 特発性細菌性腹膜炎
### Cancerous Peritonitis / 癌性腹膜炎
### Pseudomyxoma Peritonei / 腹膜偽粘液腫

## Liver Disease / 肝疾患

### Hepatitis A / A型肝炎
### Hepatitis B / B型肝炎
### Hepatitis C / C型肝炎
### Hepatitis D / D型肝炎
### Hepatitis E / E型肝炎
### Acute Viral Hepatitis / 急性ウイルス性肝炎
### Chronic Viral Hepatitis / 慢性ウイルス性肝炎
### Drug-Induced Liver Injury / 薬剤性肝障害
### Acute Liver Failure / 急性肝不全
### Fatty Liver / 脂肪肝
### Nonalcoholic Steatohepatitis / 非アルコール性脂肪性肝炎
### Alcoholic Liver Disease / アルコール性肝障害
### Autoimmune Hepatitis / 自己免疫性肝炎
### Primary Biliary Cholangitis / 原発性胆汁性胆管炎
### Primary Sclerosing Cholangitis / 原発性硬化性胆管炎
### Liver Cirrhosis / 肝硬変
### Hepatocellular Carcinoma / 肝細胞癌
### Intrahepatic Cholangiocarcinoma / 肝内胆管癌
### Metastatic Liver Tumor / 転移性肝癌
### Hepatic Hemangioma / 肝血管腫
### Hepatic Cyst / 肝嚢胞
### Liver Abscess / 肝膿瘍
### Idiopathic Portal Hypertension / 特発性門脈圧亢進症
### Budd-Chiari Syndrome / Budd-Chiari症候群

## Biliary Disease / 胆道疾患

### Cholelithiasis / 胆石症
### Acute Cholecystitis / 急性胆嚢炎
### Acute Cholangitis / 急性胆管炎
### Gallbladder Adenomyomatosis / 胆嚢腺筋腫症
### Gallbladder Cancer / 胆嚢癌
### Bile Duct Cancer / 胆管癌
### Cancer of Pipilla of Vator / 乳頭部癌

## Pancreatic Disease / 膵疾患

### Acute Pancreatitis / 急性膵炎
### Chronic Pancreatitis / 慢性膵炎
### Autoimmune Pancreatitis / 自己免疫性膵炎
### Pancreatic Carcinoma / 膵癌
### Pancreatic Psuedocyst / 膵仮性嚢胞
### Intraductal Papillary Mucinous Neoplasm / 膵管内乳頭粘液性腫瘍
### Mucinous Cystic Neoplasm / 粘液性嚢胞腫瘍
### Serous Cystic Neoplasm / 漿液性嚢胞腫瘍
### Pancreatic Neuroendocrine Neoplasm / 膵神経内分泌腫瘍 -->

# Endocrinology / 内分泌科

## Introduction / 総論

## Pituitary Gland Disorder / 下垂体疾患

## Thyroid Gland Disorder / 甲状腺疾患

## Parathyroid Gland Disorder / 副甲状腺疾患

## Adrenal Gland Disorder / 副腎疾患

## Neuroendocrine Tumor / 神経内分泌腫瘍

## Carbohydrate and Lipid Metabolism Disorder / 糖・脂質代謝異常

## Uric Acid and Bone Metabolism Disorder / 尿酸・骨代謝異常

## Congenital Metabolism Disorder / 先天代謝異常

## Nutritional Disorder / 栄養異常

<!-- ### Endocrine Organ / 内分泌器

* **Pituitary gland**
  * **Structure**: Anterior lobe (adenophysis), posterior lobe (neurophysis)
  * **Artery**: Superior hypophyseal artery (anterior lobe, hypophyseal portal system), inferior hypophyseal artery (posterior lobe)
  * **Cell (anterior)**: Acidophil (GH, PRL), basophil (TSH, FSL, LH, ACTH), chromophobe
  * **Cell (posterior)**: Nerve fiber (ADH, oxytocin from hypothalamus), pituicyte
* **Thyroid gland**
  * **Structure**: 2 lobes, isthmus
  * **Artery**: Superior thyroid artery (external carotid artery), inferior thyroid artery (thyrocervical trunk)
  * **Vein**: Superior thyroid vein (internal carotid vein), middle thyroid vein (internal carotid vein), inferior thyroid vein (brachiocephalic vein)
  * **Cell**: Follicular cell (thyroid hormone), parafollicular cell (calcitonin)
* **Parathyroid gland**
  * **Structure**: 2 upper glands, 2 lower glands
  * **Cell**: Chief cell (parathyroid hormone), oxyphil cell
* **Adrenal gland**
  * **Structure**: Adrenal cortex, adrenal medulla
  * **Artery**: Superior suprarenal artery (inferior phrenic artery), middle suprarenal artery (abdominal aorta), inferior suprarenal artery (renal artery)
  * **Vein**: Right suprarenal vein (inferior vena cava), left suprarenal vein (left renal vein)
  * **Adrenal cortex**: Zona glomerulosa (mineralcorticoid), zona fasciculata (glucocorticoid), zona reticulata (sex hormone)
  * **Adrenal medulla**: Chromaffin cell (epinephrine, norepinephrine), sympathetic presynaptic fiber
{: .notice--info} -->

<!-- ### Hypothalamus and Pituitary Hormone / 視床下部・下垂体ホルモン

* **Somatostatin analog**
  * **Drugs**: Octreotide, lantreotide
  * **Mechanism**: Somatostatin analog (decrease GH)
  * **Indication**: Acromegaly, esophageal variceal bleeding
* **GH agonist**
  * **Drugs**: Somatropin, somatrem, mecasermin
  * **Mechanism**: recombinant GH (somatropin, somatrem), recombinant IGF-1 (mecasermin)
  * **Indication**: Acromegaly, variceal bleeding
* **GH antagonist**
  * **Drugs**: Pegvisomant
  * **Mechanism**: GH antagonist
  * **Indication**: Acromegaly
* **Dopamine analog**
  * **Drugs**: Bromocriptine, cabergoline
  * **Mechanism**: Dopamine analog (decrease prolactin)
  * **Indication**: Hyperprolactenemia
* **GnRH agonist**
  * **Drugs**: Leuprolide, goserelin
  * **Mechanism**: GnRH agonist (pulsatile: increase FSH and LH, chronic: decrease FSH and LH)
  * **Indication**: Prostate cancer, endometriosis
* **GnRH antagonist**
  * **Drugs**: Abarelix, ganirelix
  * **Mechanism**: GnRH antagonist (decrease FSH and LH)
  * **Indication**: Prostate cancer, controlled ovarian stimulation
* **ADH agonist**
  * **Drugs**: Desmopressin
  * **Mechanism**: ADH V2 agonist
  * **Indication**: Central diabetes indipidus, hemophilia A
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: ADH V1/2 antagonist
  * **Indication**: SIADH
{: .notice--info}

### Thyroid Hormone / 甲状腺ホルモン

* **Thyroid hormone**
  * **Drugs**: Liothyronine (T3), levothyroxine (T4), liotrix (mix)
  * **Mechanism**: Thyroid hormone
  * **Indication**: Hypothyroidism
* **Thioamide**
  * **Drugs**: Propylthiouracil, methimazole, carbimazole
  * **Mechanism**: Inhibit T4/T3 synthesis and conversion
  * **Indication**: Hyperthyroidism
  * **Adverse effect**: Agranulocytosis
* **Iodide**
  * **Drugs**: Iodide, lithium
  * **Mechanism**: Inhibit T4/T3 release, decrease thyroid vascularity
  * **Indication**: Before thyroid surgery 
* **Radioactive iodide**
  * **Drugs**: I-131
  * **Mechanism**: Destruct thyroid gland
  * **Indication**: Hyperthyroidism, thyroid carcinoma
* **Anion inhibitor**
  * **Drugs**: Perchlorate, pertechnetate, thriocyanate
  * **Mechanism**: Inhibit iodide entry
  * **Indication**: Hyperthyroidism
* **Other therapy**
  * **Drugs**: β-blocker, hydrocortisone
  * **Mechanism**: Inhibit T4/T3 conversion, release symptom
{: .notice--info}

### Adrenal Cortical Hormone / 副腎髄質ホルモン

* **Glucocorticoid**
  * **Drugs**: Short-acting: Cortisol, cortisone / Intermediate-acting: Prednisone, prednisolone, methylprednisolone, triamcinolone / Long-acting: Betamethasone, dexamethasone
  * **Mechanism**: GR receptor agonist
  * **Indication**: Inflammation, replacement therapy, Cushing syndrome diagnosis (dexamethasone)
  * **Adverse effect**: Adrenal suppression, hyperglycemia, osteoporosis, peptic ulcer
* **Mineralcorticoid**
  * **Drugs**: Desoxycorticosterone, fludrocortisone
  * **Mechanism**: MR receptor agonist
  * **Indication**: Replacement therapy
* **Synthesis inhibitor**
  * **Drugs**: Ketoconazole, metyrapone, aminoglutethimide
  * **Mechanism**: 17α-hydroxylase inhibitor (ketoconazole), 11β-hydroxylase inhibitor (metyrapone), cholesterol side chain cleaving enzyme inhibitor (aminoglutethimide)
  * **Indication**: Cushing syndrome, pituitary function test (metyrapone)
{: .notice--info}

### Sex Hormone / 性ホルモン

* **Estrogen**
  * **Drugs**: Estradiol, mestranol
  * **Mechanism**: Estrogen
  * **Indication**: Menopausal therapy, contraception
  * **Adverse effect**: Endometrial cancer, breast cancer
* **SERM**
  * **Drugs**: Clomiphene, raloxifene, tamoxifen
  * **Mechanism**: Selective estrogen receptor modulator
  * **Indication**: Ovary dysfunction infertility (clomiphene), osteoporosis (raloxifene), breast cancer (tamoxifen)
* **Estrogen antagonist**
  * **Drugs**: Fulvestrant
  * **Mechanism**: Estrogen antagonist
  * **Indication**: Breast cancer
* **Aromatase inhibitor**
  * **Drugs**: Letrozole, anastrolzole, exemestane
  * **Mechanism**: Aromatase inhibitor (decrease estrogen)
  * **Indication**: Breast cancer
* **Progestin**
  * **Drugs**: Norgestrel, desogestrol
  * **Mechanism**: Progestin
  * **Indication**: Endometriosis, contraception (with estrogen)
* **Progestin antagonist**
  * **Drugs**: Mifepristone
  * **Mechanism**: Progestin antagonist
  * **Indication**: Abortion
* **Androgen**
  * **Drugs**: Testosterone, oxandrolone, danazol
  * **Mechanism**: Androgen
  * **Indication**: Hypogonadism, endometriosis (danazol)
  * **Adverse effect**: Decreased testicular function
* **Androgen antagonist**
  * **Drugs**: Cyproterone, flutamide, bicalutamide, spironolactone
  * **Mechanism**: Androgen antagonist
  * **Indication**: Prostate cancer
* **5α-reductase inhibitor**
  * **Drugs**: Finasteride
  * **Mechanism**: 5α-reductase inhibitor (decrease DHT)
  * **Indication**: BPH, male-pattern baldness
{: .notice--info}

### Glucose Homeostasis / 糖代謝の薬

* **Insulin**
  * **Drugs**: Rapid-acting: insulin lispro, insulin aspart / Short-acting: Regular insulin / Intermediate-acting: NPH / Long-acting: insulin glargine, insulin detemir, insulin degludec
  * **Mechanism**: Insulin
  * **Indication**: Diabetes mellitus
* **Sulfonylurea**
  * **Drugs**: Glyburide, glipizide, glimepiride, tolbutamide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Meglitinide**
  * **Drugs**: Rapaglinide, nateglinide
  * **Mechanism**: Inhibit ATP-dependent K channel (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **GLP-1 agonist**
  * **Drugs**: Exenatide, liraglutide
  * **Mechanism**: GLP-1 analog (increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **DPP-4 inhibitor**
  * **Drugs**: Sitagliptin, saxagliptin
  * **Mechanism**: DPP-4 inhibitor (increase GLP-1, increase insulin secretion)
  * **Indication**: Diabetes mellitus
* **Biguanide**
  * **Drugs**: Metformin
  * **Mechanism**: Reduce hepatic gluconeogenesis
  * **Indication**: Diabetes mellitus
* **Thiazolidinedione**
  * **Drugs**: Troglitazone, rosiglitazone
  * **Mechanism**: Activate PPARγ (decrease insulin resistance)
  * **Indication**: Diabetes mellitus
* **α-glucosidase inhibitor**
  * **Drugs**: Acarbose
  * **Mechanism**: α-glucosidase inhibitor (decrease intestinal glucose absorption)
  * **Indication**: Diabetes mellitus
* **SGLT2 inhibitor**
  * **Drugs**: Canagliflozin, empagliflozin
  * **Mechanism**: SGLT2 inhibitor (decrease renal glucose reabsorption)
  * **Indication**: Diabetes mellitus
* **Amylin analog**
  * **Drugs**: Pramlintide
  * **Mechanism**: Amylin analog
  * **Indication**: Diabetes mellitus
{: .notice--info}

### Calcium Homeostasis Drug / カルシウム代謝の薬

* **Bisphosphonate**
  * **Drugs**: Alendronate, risedronate, pamidronate
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Osteoporosis
* **Anti-RANKL antibody**
  * **Drugs**: Denosumab
  * **Mechanism**: Anti-RANKL antibody (inhibit osteoclast)
  * **Indication**: Osteoporosis
* **Parathyroid hormone**
  * **Drugs**: Teriparatide
  * **Mechanism**: Stimulate osteoblast
  * **Indication**: Osteoporosis
* **Calcitonin**
  * **Drugs**: Calcitonin
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Paget disease
* **Vitamin D**
  * **Drugs**: Cholecalciferol
  * **Mechanism**: Increase Ca absorption and reabsorption
  * **Indication**: Osteomalacia
* **SERM**
  * **Drugs**: Raloxifene, estrogen
  * **Mechanism**: Inhibit osteoclast
  * **Indication**: Postmenopausal osteoporosis
{: .notice--info}

### Retinoic Acid / レチノイン酸

* **Tretinoin**
  * **Drugs**: Tretinoin
  * **Mechanism**: Modify epithelial growth and turnover
  * **Indication**: Acne, photo-aged skin, acute promyelocytic leukemia
  * **Adverse effect**: Sunburn
* **Isotretinoin**
  * **Drugs**: Isotretinoin
  * **Mechanism**: Reduce sebaceous gland size
  * **Indication**: Severe cystic acne
  * **Adverse effect**: Teratogenic
* **Acitretin**
  * **Drugs**: Acitretin
  * **Mechanism**: Inhibit proinflammatory cytokine expression
  * **Indication**: Psoriases
  * **Adverse effect**: Skin and nail abnormality, teratogenic
{: .notice--info} -->

<!-- ## Hypothalamus and Pituitary Gland Disease / 視床下部・下垂体疾患

### Hyperprolactinemia / 高プロラクチン血症
### Acromegaly / 先端肥大症
### Cushing's Disease / Cushing病
### Hypopituitarism / 下垂体前葉機能低下症
### Central Diabetes Insipidus / 中枢性尿崩症
### SIADH / バゾプレシン不適合分泌症候群

## Thyroid Gland Disease / 甲状腺疾患

### Grave's Disease / Basedow病
### Plummer Disease / Plummer病
### Acute Thyroiditis / 急性甲状腺炎
### Subacute Thyroiditis / 亜急性甲状腺炎
### Painless Thyroiditis / 無痛性甲状腺炎
### Chronic Thyroiditis / 慢性甲状腺炎
### Simple Goiter / 単純性甲状腺腫
### Multinodular Goiter / 多結節性甲状腺腫
### Thyroid Cancer / 甲状腺癌

## Parathyroid Gland Disease / 副甲状腺疾患

### Primary Hyperparathyroidism / 原発性副甲状腺機能亢進症
### Renal Hyperparathyroidism / 腎性副甲状腺機能亢進症
### Malignancy-Related Hypercalcemia / 悪性腫瘍関連高カルシウム血症
### Hypoparathyroidism / 副甲状腺機能低下症
### Pseudohypoparathyroidism / 偽性副甲状腺機能低下症

## Adrenal Gland Disease / 副腎疾患

### Cushing's Syndrome / Cushing症候群
### Primary Aldosteronism / 原発性アルドステロン症
### Addison's Disease / Addison病
### Acute Adrenal Insufficiency / 急性副腎不全
### Pheochromocytoma / 褐色細胞腫

## Other Endocrine Disease / その他の内分泌疾患

### MEN / 多発性内分泌腺腫症
### Insulinoma / インスリノーマ
### Gastrinoma / ガストリノーマ
### Glucagonoma / グルカゴノーマ
### VIPoma / VIPoma

## Glucose Metabolism Disorder / 糖代謝異常

### Type 1 Diabetes Mellitus / 1型糖尿病
### Type 2 Diabetes Mellitus / 2型糖尿病
### Maturity-Onset Diabetes of the Young / 若年発症成人型糖尿病
### Gestational Diabetes Mellitis / 妊娠糖尿病
### Diabetic Ketoacidosis / 糖尿病性ケトアシドーシス
### Hyperosmolar Hyperglycemic Syndrome / 高浸透圧高血糖症候群
### Diabetic Foot / 糖尿病足病変
### Hypoglycemia / 低血糖症

## Lipid and Nutrition Metabolism Disorder / 脂質・栄養代謝異常

### Dyslipidemia / 脂質異常症
### Familial Hypercholesterolemia / 家族性高コレステロール血症
### Obesity Disease / 肥満症
### Metabolic Syndrome / メタボリックシンドローム
### Vitamin A Deficiency / ビタミンA欠乏症
### Vitamin B1 Deficiency / ビタミンB1欠乏症
### Vitamin B3 Deficiency / ビタミンB3欠乏症
### Vitamin B6 Deficiency / ビタミンB6欠乏症
### Vitamin B12 Deficiency / ビタミンB12欠乏症
### Vitamin C Deficiency / ビタミンC欠乏症
### Vitamin D Deficiency / ビタミンD欠乏症
### Vitamin E Deficiency / ビタミンE欠乏症
### Vitamin K Deficiency / ビタミンK欠乏症
### Zinc Deficiency / 亜鉛欠乏症
### Copper Deficiency / 銅欠乏症
### Malnutrition Syndrome / 栄養不良症候群

## Other Metabolism Disorder / その他の代謝異常

### Hyperuricemia / 高尿酸血症
### Gout / 痛風
### Pseudogout / 偽痛風
### Osteoporosis / 骨粗鬆症
### Osteopetrosis / 骨硬化症
### Paget's Disease of Bone / 骨Paget病
### Hemochromatosis / ヘモクロマトーシス
### Acute Intermittent Porphyria / 急性間欠性ポルフィリン症
### Porphyria Cutanea Tarda / 晩発性皮膚ポルフィリン症
### Amyloidosis / アミロイドーシス -->

# Nephrology / 腎臓科

## Introduction / 総論

## Electrolytes Metabolism Disorder / 電解質代謝異常

## Glomerular Disorder / 糸球体疾患

## Tubulointerstitial Disorder / 尿細管・間質性疾患

## Renal Injury with Systemic Disorder / 全身性疾患に伴う腎障害

## Renal Vascular Disorder / 腎血管性疾患

## Renal Failure / 腎不全

<!-- ## Introduction /　総論

### Diuretics / 利尿薬

* **Carbonic anhydrase inhibitor**
  * **Drugs**: Acetazolamide
  * **Mechanism**: Inhibit carbonic anhydrase
  * **Indication**: Glaucoma, urine alkalinization
  * **Adverse effect**: Acidosis, renal calculi
* **Loop diuretics**
  * **Drugs**: Furosemide, bumetanide, torsemide, ethacrynic acid
  * **Mechanism**: Inhibit Na-K-2Cl contransporter
  * **Indication**: Acute pulmonary edema, congestive heart failure
  * **Adverse effect**: Hypokalemia, hypocalcemia, alkalosis, ototoxicity (with aminoglycoside)
* **Thiazide diuretics**
  * **Drugs**: Hydrochlorothiazide, chlorothiazide
  * **Mechanism**: Inhibit Na-Cl contransporter
  * **Indication**: Hypertension, nephrogenic diabetes insipidus
  * **Adverse effect**: Hypokalemia, hypercalcemia, alkalosis, hyperuricemia, hyperglycemia
* **Potassium-sparing diuretics**
  * **Drugs**: Spironolactone, eplerenone, amiloride, triamterene
  * **Mechanism**: Aldosterone antagonist (spironolactone, eplerenone), ENac blocker (amiloride, triamterene)
  * **Indication**: Hyperaldosteronism, prevent K+ loss
  * **Adverse effect**: Hyperkalemia, acidosis, gynecomastia (spironolactone)
* **Osmotic diuretics**
  * **Drugs**: Mannitol
  * **Mechanism**: Inhibit water reabsorption
  * **Indication**: Reduce intracranial and intraocular pressure 
* **ADH antagonist**
  * **Drugs**: Conivaptan, tolvaptan, demeclocycline
  * **Mechanism**: V1 and/or V2 antagonist
  * **Indication**: SIADH
{: .notice--info} -->

<!-- ## Water and Electrolytes Metabolism Disorder / 水・電解質代謝異常

### Hyponatremia / 低ナトリウム血症
### Hypernatremia / 高ナトリウム血症
### Hypokalemia / 低カリウム血症
### Hyperkalemia / 高カリウム血症
### Hypocalcemia / 低カルシウム血症
### Hypercalcemia / 高カルシウム血症
### Hypophosphatemia / 低リン血症
### Hyperphosphatemia / 高リン血症
### Hypomagnesemia / 低マグネシウム血症
### Hypermagnesemia / 高マグネシウム血症
### Metabolic Acidosis / 代謝性アシドーシス
### Metabolic Alkalosis / 代謝性アルカローシス
### Respiratory Acidosis / 呼吸性アシドーシス
### Respiratory Alkalosis / 呼吸性アルカローシス

## Glomerular Disease / 糸球体疾患

### Acute Glomerulonephritis / 急性糸球体腎炎
### Rapid Progressive Glomerulonephritis / 急速進行性糸球体腎炎
### IgA Nephropathy / IgA腎症
### Minimal Change Nephrotic Syndrome / 微小変化型ネフローゼ症候群
### Membranous Nephropathy / 膜性腎症
### Focal Segmental Glomerulosclerosis / 巣状分節性糸球体硬化症
### Membranoproliferative Glomerulonephritis / 膜性増殖性糸球体腎炎
### Alport's Syndrome / Alport症候群
### Benign Familial Hematuria / 良性家族性血尿

## Tubulointerstitial Disease / 尿細管・間質性疾患

### Fanconi Syndrome / Fanconi症候群
### Bartter's Syndrome / Bartter症候群
### Pseudo-Bartter's Syndrome / 偽性Bartter症候群
### Gitelman's Syndrome / Gitelman症候群
### Liddle's Syndrome / Liddle症候群
### Nephrogenic Diabetes Insipidus / 腎性尿崩症
### Renal Tubular Acidosis / 尿細管性アシドーシス
### Tubulointerstitial Nephritis / 尿細管間質性腎炎

## Renal Injury with Systemic Disease / 全身性疾患に伴う腎障害

### Diabetic Nephropathy / 糖尿病性腎症
### Gouty Kidney / 痛風腎
### Myeloma Kidney / 骨髄腫腎
### Cryoglobulin Nephropathy / クリオグロブリン血症性腎症
### Amyloid Nephropathy / アミロイド腎症
### Lupus Nephritis / ループス腎炎
### Scleroderma Kidney / 強皮症腎
### Drug-Induced Kidney Injury / 薬剤性腎障害

## Renal Vascular Disease / 腎血管性疾患

### Renovascular Hypertension / 腎血管性高血圧
### Benign Nephrosclerosis / 良性腎硬化症
### Malignant Nephrosclerosis / 悪性腎硬化症
### Renal Infarction / 腎梗塞
### Renal Papillary Necrosis / 腎乳頭壊死
### Renal Cortical Necrosis / 腎皮質壊死
### Renal Vein Thrombosis / 腎静脈血栓症

## Renal Failure / 腎不全

### Acute Kidney Injury / 急性腎障害
### Chronic Kidney Disease / 慢性腎臓病
### Disequilibrium Syndrome / 不均衡症候群
### CKD Mineral and Bone Disorder / CKDに伴う骨ミネラル代謝異常
### Dialysis Amyloidosis / 透析アミロイドーシス
### Renal Anemia / 腎性貧血 -->

# Hematology / 血液科

## Introduction / 総論

## Hemostasis Disorder (Primary) / 止血の異常（一次）

## Hemostasis Disorder (Secondary) / 止血の異常（二次）

## Red Blood Cell Disorder (Nonehemolysis) / 赤血球の異常（非溶血）

## Red Blood Cell Disorder (Hemolysis) / 赤血球の異常（溶血）

## White Blood Cell Disorder / 白血球の異常

## Myeloid Neoplasm / 骨髄系腫瘍

## Lymphoid Neoplasm / リンパ系腫瘍

<!-- ## Introduction /　総論

### Alkylating Drug / アルキル化薬

* **Nitrogen mustard**
  * **Drug**: Cyclophosphamide, ifosfamide
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hemorrhagic cystitis (due to acrolein, prevented by mesna)
* **Nitrosoureas**
  * **Drug**: Carmustine, lomustine
  * **Mechanism**: Directly damage DNA
  * **Indication**: Brain tumor (cross BBB)
  * **Adverse effect**: Myelosuppression, pulmonary toxicity
* **Alkyl sulfonate**
  * **Drug**: Busfulfan
  * **Mechanism**: Directly damage DNA
  * **Indication**: Before bone marrow transplantation
  * **Adverse effect**: Myelosuppression, pulmonary fibrosis, hyperpigmentation
* **Platinum analog**
  * **Drug**: Cisplatin, carboplatin, oxaliplatin
  * **Mechanism**: Directly damage DNA
  * **Indication**: Various tumor
  * **Adverse effect**: Myelosuppresion, nephrotoxicity, otoxicity, peripheral neuropathy
{: .notice--info}

### Antimetabolte / 代謝拮抗薬

* **Folic acid analog**
  * **Drug**: Methotrexate, pemetrexed
  * **Mechanism**: Inhibit dihydrofolate reductase, inhibit thymidylate synthetase (pemetrexed)
  * **Indication**: Leukemia and lymphoma, autoimmune disease (methotrexate), mesothelioma, non-small cell lung cancer (pemetrexed)
  * **Adverse effect**: Myelosuppresion, mucositis, nephrotoxicity (rescued by leucovorin)
* **5-Fluorouracil**
  * **Drug**: 5-Fluorouracil, capecitabine
  * **Mechanism**:  Inhibit thymidylate synthetase (5F-dUMP)
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, hand-and-foot syndrome
* **Pyrimidine analog**
  * **Drug**: Cytarabine, gemticabine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
* **Purine analog**
  * **Drug**: 6-Mercaptopurine, cladribine
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: Leukemia
  * **Adverse effect**: Myelosuppression, interact with allopurinol
* **Hydroxyuria**
  * **Drug**: Hydroxyuria
  * **Mechanism**: Inhibit ribonucleoside diphosphate reductase
  * **Indication**: Leukemia, sickle cell anemia
  * **Adverse effect**: Myelosuppression, GI distress
{: .notice--info}

### Microtubule Damaging Drug / 微小管阻害薬

* **Vinca alkaloids**
  * **Drug**: Vinblastine, vincristine, vinorelbine
  * **Mechanism**: Inhibit microtubule polymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy
* **Taxanes**
  * **Drug**: Paclitaxel, docltaxel, cabazitaxel
  * **Mechanism**: Inhibit microtubule depolymerization
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, peripheral neuropathy, hypersensitivity (paclitaxel), fluid retention (docetaxel)
{: .notice--info}

### Topoisomerase Inhibitor / トポイソメラーゼ阻害薬

* **Topoisomerase I inhibitor**
  * **Drug**: Topotecan, irinotecan
  * **Mechanism**: Topoisomerase I inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, diarrhea, secondary leukemia
* **Topoisomerase II inhibitor**
  * **Drug**: Etoposide
  * **Mechanism**: Topoisomerase II inhibitor
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression
{: .notice--info}

### Antitumor Antibiotics / 抗腫瘍性抗生物質

* **Antrhacyclines**
  * **Drug**: Doxorubicin, daunorubicin, idarubicin, epirubicin
  * **Mechanism**: Inhibit topoisomerase II, intercalate between DNA base pairs, form oxygen free radical
  * **Indication**: Various cancer
  * **Adverse effect**: Myelosuppression, cardiotoxicity (dexrazoxane protect)
* **Dactinomycin**
  * **Drug**: Dactinomycin
  * **Mechanism**: Intercalate between DNA base pairs
  * **Indication**: Pediatric cancer
  * **Adverse effect**: Myelosuppression
* **Bleomycin**
  * **Drug**: Bleomycin
  * **Mechanism**: Form oxygen free radical
  * **Indication**: Testicular cancer
  * **Adverse effect**: Pulmonary toxicity, hyperpigmentation
{: .notice--info}

### Target Therapy / 分子標的薬

* **Monoclonal antibody (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20
  * **Indication**: Non-Hodgkin lymphoma, chronic lymphocytic leukemia
* **Monoclonal antibody (CD30)**
  * **Drug**: Brentuximab vedotin
  * **Mechanism**: Anti-CD30
  * **Indication**: Hodgkin lymphoma
* **Monoclonal antibody (HER2)**
  * **Drug**: Trastuzumab, pertuzumab
  * **Mechanism**: Anti-HER2
  * **Indication**: Breast cancer, gastric cancer
* **Monoclonal antibody (EGFR)**
  * **Drug**: Cetuximab, panitumumab, necitumumab
  * **Mechanism**: Anti-EGFR
  * **Indication**: Metastatic colorectal cancer (KRAS wild-type)
* **Monoclonal antibody (VEGF)**
  * **Drug**: Bevacizumab, ramucirumab
  * **Mechanism**: Anti-VEGF (inhibit microvascular growth)
  * **Indication**: Various cancer
* **Tyrosine kinase inhibitor (BCR-ABL)**
  * **Drug**: Imatinib, dasatinib, nilotinib, and ponatinib
  * **Mechanism**: BCR-ABL inhibitor
  * **Indication**: Leukemia and lymphoma (Philadelphia chromosome-positive) 
* **Tyrosine kinase inhibitor (EGFR)**
  * **Drug**: Gatitinib, erlotinib
  * **Mechanism**: EFGR inhibitor
  * **Indication**: NSCLC
* **Tyrosine kinase inhibitor (BRAF)**
  * **Drug**: Vemurafenib
  * **Mechanism**: BRAF inhibitor
  * **Indication**: Melanoma (BRAF V600E)
* **Immune checkpoint inhibitor (CTLA-4)**
  * **Drug**: Ipilimumab
  * **Mechanism**: Anti-CTLA-4, enhance T-cell activation
  * **Indication**: Melanoma
* **Immune checkpoint inhibitor (PD-1)**
  * **Drug**: Pembrolizumab, nivolumab, cemiplimab
  * **Mechanism**: Anti-PD-1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immune checkpoint inhibitor (PD-L1)**
  * **Drug**: Atezolizumab, durvalumab, avelumab
  * **Mechanism**: Anti-PD-L1, enhance T-cell activation
  * **Indication**: Various cancer
* **Immunomodulator**
  * **Drug**: Thalidomide, lenalidomide
  * **Mechanism**: Inhibit proinflammatory cytokines secretion, enhance call-mediated immunity
  * **Indication**: Multiple myeloma
  * **Adverse effect**: Birth defect
{: .notice--info} -->

<!-- ## Nonhemolytic Anemia / 非溶血性貧血

### Iron Deficiency Anemia / 鉄欠乏性貧血
### Sideroblastic Anemia / 鉄芽球性貧血
### Secondary Anemia / 二次性貧血
### Aplastic Anemia / 再生不良性貧血
### Pure Red Cell Aplasia / 赤芽球癆
### Megaloblastic Anemia / 巨赤芽球性貧血

## Hemolytic Anemia / 溶血性貧血

### Hereditary Spherocytosis / 遺伝性球状赤血球症
### Thalassemia / サラセミア
### Sickle Cell Disease / 鎌状赤血球症
### G6PD Deficiency / G6PD異常症
### Pyruvate Kinase Deficiency / PK異常症
### Paroxysmal Nocturnal Hemoglobinuria / 発作性夜間ヘモグロビン尿症
### Autoimmune Hemolytic Anemia / 自己免疫性溶血性貧血
### Red Cell Fragmentation Syndrome / 赤血球破砕症候群

## Leukemia / 白血病

### Acute Myeloid Leukemia / 急性骨髄性白血病
### Acute Lymphoblastic Leukemia / 急性リンパ性白血病
### Chronic Myeloid Leukemia / 慢性骨髄性白血病
### Chronic Lymphocytic Leukemia / 慢性リンパ性白血病
### Hairy Cell Leukemia / 有毛細胞白血病
### Adult T-cell Leukemia/Lymphoma / 成人T細胞白血病・リンパ腫

## Malignant Lymphoma / 悪性リンパ腫

### Hodgkin Lymphoma / Hodgkinリンパ腫
### Diffuse Large B-cell Lymphoma / びまん性大細胞型B細胞リンパ腫
### Follicular Lymphoma / 濾胞性リンパ腫
### MALT Lymphoma / MALTリンパ腫
### Mantle Cell Lymphoma / マントル細胞リンパ腫
### Burkitt lymphoma / Burkittリンパ腫
### Peripheral T-cell Lymphoma / 末梢性T細胞リンパ腫
### Mycosis Fungoides and Sézary Syndrome / 菌状息肉症・Sézary症候群

## Other Hematopoietic Tumors / その他の造血器腫瘍

### Myelodysplastic Syndrome / 骨髄異形成症候群
### Polycythemia Vera / 真性赤血球増加症
### Essential Thrombocythemia / 本態性血小板血症
### Primary Myelofibrosis / 原発性骨髄線維症
### Multiple Myeloma / 多発性骨髄腫
### MGUS / MGUS
### Waldenström's Macroglobulinemia / 原発性マクログロブリン血症
### Heavy-Chain Disease / H鎖病

## Other Blood Cell Disorder / その他の血球異常

### Erythrocytosis / 赤血球増加症
### Leukemoid Reaction / 類白血病反応
### Agranulocytosis / 無顆粒球症
### Infectious Mononucleosis / 伝染性単核症
### Langerhans Cell Histiocytosis / Langerhans細胞組織球症
### Hemophagocytic Syndrome / 血球貪食症候群

## Hemostasis and Coagulation Disorder / 止血・凝固系の異常

### Immune Thrombocytopenic Purpura / 免疫性血小板減少性紫斑病
### Thrombotic Thrombocytopenic Purpura / 血栓性血小板減少性紫斑病
### Hemolytic Uremic Syndrome / 溶血性尿毒症症候群
### Disseminated Intravascular Coagulation / 播種性血管内凝固
### Vitamin K Deficiency / ビタミンK欠乏症 -->

# Rheumatology / リウマチ科

## Introduction / 総論

## Immunodeficiency / 免疫不全

## Allergy / アレルギー

## Collagen Disease (Arthritis) / 膠原病（関節炎）

## Collagen Disease (Systemic) / 膠原病（全身性）

## Collagen Disease (Vasculitis) / 膠原病（血管炎）

<!-- ## Introduction /　総論

### Antiallergic Drug / 抗アレルギー薬

* **H1 antagonist (1st generation)**
  * **Drug**: Chlorpheniramine, dimenhydrinate, diphenhydramine, doxylamine, meclizine, promethazine
  * **Mechanism**: H1 receptor antagonist (pass BBB)
  * **Indication**: Allergic symptoms, insomnia, motion sickness, nausea and vomiting
  * **Adverse effect**: Sedation, anticholinergic
* **H1 antagonist (2st generation)**
  * **Drug**: Loratadine, cetirizine, clemastine, fexofenadine, desloratadine
  * **Mechanism**: H1 receptor antagonist (not pass BBB)
  * **Indication**: Allergic rhinitis
{: .notice--info}

### NSAID / 非ステロイド性抗炎症薬

* **Aspirin**
  * **Drug**: Aspirin
  * **Mechanism**: Inactivate COX-1 and COX-2 (irreversible)
  * **Indication**: Inflammation, pain, fever, reduce thrombi formation
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, Reye syndrome (during viral infection)
* **NSAID**
  * **Drug**: Ibuprofen, naproxen, fenoprofen, ketoprofen / indomethacin, sulindac, ketorolac, diclofenac / peroxicam, mefenamate, meclofenamate, nabumetone / celecoxib (COX-2 selective)
  * **Mechanism**: Inactivate COX-1 and COX-2 (reversible)
  * **Indication**: Inflammation (indomethacin, diclofenac), pain (ketorolac), fever (ibuprogen, naproxen)
  * **Adverse effect**: Gastrointestinal event, hypersensitivity, cardiovascular event (COX-2 selective)
* **Acetaminophen**
  * **Drug**: Acetaminophen
  * **Mechanism**: Inactivate COX (centrally acting)
  * **Indication**: Pain, fever
  * **Adverse effect**: Hepatotoxicity (due to NAPQI, treat with N-acetylcystein)
* **PGE1 agonist**
  * **Drug**: Misoprostol, alprostadil
  * **Mechanism**: PGE1 agonist
  * **Indication**: NSAID-induced ulcer (misoprostol), erectile dysfunction (alprostadil), ductus arteriosus maintenance (alprostadil)
* **PGE2 agonist**
  * **Drug**: Dinoprostone
  * **Mechanism**: PGE2 agonist
  * **Indication**: Pregnancy termination
* **PGF2α agonist**
  * **Drug**: Carboprost, latanoprost
  * **Mechanism**: PGF2α agonist
  * **Indication**: Pregnancy termination (carboprost), glaucoma (latanoprost)
* **PGI2 agonist**
  * **Drug**: Epoprostenol, treprostinil, iloprost
  * **Mechanism**: PGI2 agonist
  * **Indication**: Pulmonary hypertension
{: .notice--info}

### Gout Drug / 痛風の薬

* **Colchicine**
  * **Drug**: Colchicine
  * **Mechanism**: Prevent tubulin polymerization, interfere neutrophil migration
  * **Indication**: Acute gouty arthritis
  * **Adverse effect**: Gatrointestinal distress
* **Allopurinol**
  * **Drug**: Allopurinol, feboxostat
  * **Mechanism**: Xanthine oxidase inhibitor
  * **Indication**: Chronic gout
  * **Adverse effect**: Skin rash, GI distress
* **Porbenecid**
  * **Drug**: Compatitively inhibits reabaorption
of urate
  * **Mechanism**: Chronic gout
  * **Indication**: Urolithiasis
  * **Adverse effect**: Reduct other drugs excretion (penicillin)
* **Pegloticase**
  * **Drug**: Pegloticase
  * **Mechanism**: Recombinant uricase
  * **Indication**: Chronic gout
  * **Adverse effect**: Anaphylaxis
{: .notice--info}

### Immunosuppressive Drug / 免疫抑制薬

* **Calcineurin inhibitor**
  * **Drug**: Cyclosporine, tacralimus
  * **Mechanism**: Calcineurin inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Nephrotoxicity, gingival hyperplasia (cyclosporine)
* **mTOR inhibitor**
  * **Drug**: Sirolimus
  * **Mechanism**: mTOR inhibitor
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: Anemia, increased cholesterol
* **Antimetabolite**
  * **Drug**: Azathioprine, mycophenolate mofetil, leflunomide
  * **Mechanism**: Inhibit DNA synthesis (Azathioprine: converted to 6-MP) (Mycophenolate mofetil: inhibit inosine monophosphate dehydrogenase) (Leflunomide: inhibit dihydroorotate dehydrogenase)
  * **Indication**: Solid-organ transplant, autoimmune disease
  * **Adverse effect**: GI distress, leukopenia, interact with allopurinol (azathioprine)
* **Biologic agent (TNF-α)**
  * **Drug**: Infliximab, adalimumab, certolizumab, golimumab, etanercept
  * **Mechanism**: Block TNF-α 
  * **Indication**: Autoimmune diseases
* **Biologic agent (IL-1)**
  * **Drug**: Anakinra
  * **Mechanism**: IL-1 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (IL-6 receptor)**
  * **Drug**: Tocilizumab
  * **Mechanism**: IL-6 receptor antagonist
  * **Indication**: Rheumatold arthritis
* **Biologic agent (JAK-STAT)**
  * **Drug**: Tofacitinib
  * **Mechanism**: Block JAK-STAT signaling
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD80/86)**
  * **Drug**: Abatacept
  * **Mechanism**: Block costimulatory signal
  * **Indication**: Rheumatold arthritis
* **Biologic agent (CD20)**
  * **Drug**: Rituximab
  * **Mechanism**: Anti-CD20 antibody
  * **Indication**: Rheumatoid arthritis, leukemia and lymphoma
* **Biologic agent (CD25)**
  * **Drug**: Basiliximab
  * **Mechanism**: Anti-CD25 antibody
  * **Indication**: Acute transplant rejection
* **Biologic agent (α4 integrin)**
  * **Drug**: Natalizumab
  * **Mechanism**: Anti-α4 integrin antibody
  * **Indication**: Multiple sclerosis, Crohn disease.
* **Antithymocyte globulin**
  * **Drug**: Antithymocyte globulin
  * **Mechanism**: Elimination of T lymphocyte
  * **Indication**: Aplastic anemia, graft-versus-host disease
{: .notice--info} -->

<!-- ## Allergy / アレルギー

### Anaphylaxis / アナフィラキシー
### Food Allergy / 食物アレルギー
### Drug Allergy / 薬物アレルギー
### Serem Sickness / 血清病

## Collagen Disease (Arthritis) / 膠原病（関節炎）

### Rheumatoid Arthritis / 関節リウマチ
### Juvenile Idiopathic Arthritis / 若年性特発性関節炎
### Adult Still's Disease / 成人Still病
### Ankylosing Spondylitis / 強直性脊椎炎
### Psoriatic Arthritis / 乾癬性関節炎
### Reactive Arthritis / 反応性関節炎

## Collagen Disease (Systemic) / 膠原病（全身性）

### Systemic Lupus Erythematosus / 全身性エリテマトーデス
### Scleroderma / 強皮症
### Polymyositis and Dermatomyositis / 多発性筋炎・皮膚筋炎
### Mixed Connective Tissue Disease / 混合性結合組織病
### Polymyalgia Rheumatica / リウマチ性多発筋痛症
### Fibromyalgia / 線維筋痛症
### Sjögren's Syndrome / Sjögren症候群
### Behcet's Disease / Behcet病
### Rheumatic Fever / リウマチ熱
### Antiphospholipid Syndrome / 抗リン脂質抗体症候群
### IgG4-Related Disease / IgG4関連疾患
### Goodpasture Syndrome / Goodpasture症候群
### Sarcoidosis / サルコイドーシス

## Collagen Disease (Vasculitis) / 膠原病（血管炎）

### Giant Cell Arteritis / 巨細胞性動脈炎
### Takayasu's Arteritis / 高安動脈炎
### Polyarteritis Nodosa / 結節性多発動脈炎
### Kawasaki Disease / 川崎病
### Microscopic Polyangiitis / 顕微鏡的多発血管炎
### Granulomatosis with Polyangiitis / 多発血管炎性肉芽腫症
### Eosinophilic Granulomatosis with Polyangiitis / 好酸球性多発血管炎性肉芽腫症
### IgA Vasculitis / IgA血管炎 -->

# Infectious Diseases / 感染症科

## Introduction / 総論

## Gram-Positive Bacteria Infection / グラム陽性菌感染症

## Gram-Negative Bacteria Infection / グラム陰性菌感染症

## Miscellaneous Bacteria Infection / その他の細菌感染症

## DNA Virus Infection / DNAウイルス感染症

## RNA Virus Infection / RNAウイルス感染症

## Fungus Infection / 真菌感染症

## Parasite Infection / 寄生虫感染症

<!-- ## Introduction /　総論

### Cell Wall Synthesis Inhibitor / 細胞壁合成阻害薬

* **Penicillins**
  * **Drug**: (Original) penicillin G, penicillin V, benzathine penicillin / (β-lactamase resistant) oxacillin, dicloxacillin, methicillin, nafcillin / (Extended-spectrum) ampicillin, amoxicillin, piperacillin, ticarcillin / (β-lactamase inhibitor) clavulanate, sulbactam, tazobactam
  * **Mechanism**: Inhibit transpeptidase, resistance from β-lactamase, synergistic with aminoglycoside
  * **Indication**: Various bacteria, pseudomonas (piperacillin, ticarcillin)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Cephalosporins**
  * **Drug**: (1st generation) cephalexin, cefazolin, cefadroxil / (2nd generation) cefoxitin, cefaclor, cefuroxime, cefotetan, cefprozil / (3rd generation)
  ceftazidime, cefperazone, ceftriazone, cefixime, cefdinir, cefotaxime / (4th generation) cefepime / (5th generation) ceftaroline
  * **Mechanism**: Inhibit transpeptidase, β-lactamase resistant, penetrate CSF (cefuroxime, 3rd generation)
  * **Indication**: Various bacteria, pseudomonas (cefoperazone, ceftazidime, cefepime), gonorrhea (ceftriaxone, cefixime), MRSA (ceftaroline)
  * **Adverse effect**: Hypersensitivity, GI disturbances
* **Carbapenems**
  * **Drug**: Imipenem (+ cilastatin), ertapenem, meropenem, doripenem
  * **Mechanism**: Inhibit transpeptidase, β-lactamase resistant, (cilastin: inhibit renal dehydropeptidase)
  * **Indication**: Various bacteria
  * **Adverse effect**: Hypersensitivity
* **Monobactam**
  * **Drug**: Aztreonam
  * **Mechanism**: Inhibit transpeptidase, β-lactamase resistant
  * **Indication**: Gram-negative (penicillin hypersensitivity)
* **Glycopeptides**
  * **Drug**: Vancomycin, telavancin, dalbavancin, oritavancin
  * **Mechanism**: Inhibit transglycosylase
  * **Indication**: Gram-positive (penicillin hypersensitivity), MRSA
  * **Adverse effect**: Red man syndrome, nephrotoxicity
* **Daptomycin**
  * **Drug**: Daptomycin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-positive, MRSA
  * **Adverse effect**: Myopathy
* **Polymyxin**
  * **Drug**: Polymyxin
  * **Mechanism**: Disrupt cell membrane
  * **Indication**: Gram-negative
  * **Adverse effect**: Nephrotoxicity, neurotoxicity
{: .notice--info}

### Protein Synthesis Inhibitor / タンパク質合成阻害薬

* **Aminoglycosides**
  * **Drug**: Streptomycin, gentamicin, tobramycin, neomycin, amikacin
  * **Mechanism**: Inhibit 30S ribosomal subunit, require active transport (anaerobe resistant), synergistic with β-lactam
  * **Indication**: Gram-negative, aerobe
  * **Adverse effect**: Nephrotoxic, ototoxic, neuromuscular blockade
* **Tetracyclines**
  * **Drug**: Tetracycline, demeclocycline, doxycycline, minocycline, tigecycline
  * **Mechanism**: Inhibit 30S ribosomal subunit
  * **Indication**: Rickatlsia, chlamydia, mycoplasma, acne vulgaris, MRSA (tigecycline)
  * **Adverse effect**: Tooth discoloration, growth inhibition, photosensitivity, calcium impair absorption
* **Macrolides**
  * **Drug**: Azithromycin, clarithromycin, erythromycin, telithromycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Legionella, mycoplasma
  * **Adverse effect**: QT prolongation, inhibit CYP450
* **Lincosamide**
  * **Drug**: Clindamycin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Anaerobe, ance
  * **Adverse effect**: Pseudomembranous colitis
* **Oxazolidinones**
  * **Drug**: Linezolid
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Gram-positive, VRE
  * **Adverse effect**: Thrombocytopenia, serotonin syndrome
* **Amphenicol**
  * **Drug**: Chloramphenicol
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: Various bacteria
  * **Adverse effect**: Aplastic anemia, hemolytic anemia (G6PD deficienct), gray baby syndrome
* **Streptogramins**
  * **Drug**: Quinupristin, dalfopristin
  * **Mechanism**: Inhibit 50S subunit
  * **Indication**: VRE, MRSA
{: .notice--info}

### DNA Synthesis Inhibitor / 核酸合成阻害薬

* **Antifolate drug**
  * **Drug**: Trimethoprim + sulfamethoxazole
  * **Mechanism**: Inhibit dihydropteroate synthase (sulfamethoxazole), inhibit dihydrofolate reductase (trimethoprim)
  * **Indication**: Urinary tract infections, pneumocystis pneumonia
  * **Adverse effect**: Hypenensitivity, Stevens-Johnson syndrome, hemolytic anemia (G6PD deficiency)
* **Fluoroquinolones**
  * **Drug**: Ciprofloxacin, norfloxacin, ofloxacin, levofloxacin, moxifloxacin, gemifloxacin
  * **Mechanism**: Inhibit DNA gyrase, inhibit topoisomerase IV
  * **Indication**: Urinary tract infections, respiratory tract infections
  * **Adverse effect**: QT prolongation, tendon rupture
* **Metronidazole**
  * **Drug**: Metronidazole
  * **Mechanism**: Form free radical
  * **Indication**: Trichomonas vaginalis, pseudomembranous colitis
  * **Adverse effect**: Peripheral neuropathy, ditulfiram-like reaction
{: .notice--info}

### Antimycobacterial Drug / 抗結核薬

* **Isoniazid**
  * **Drug**: Isoniazid
  * **Mechanism**: Inhibit mycobactarial call wall synthesis
  * **Indication**: Tuberculosis (combination), prophylaxis
  * **Adverse effect**: Peripheral nauropathy (minimized by pyridoxine), hepatotoxicity
* **Rifampin**
  * **Drug**: Rifampin
  * **Mechanism**: Inhibits RNA polymerase
  * **Indication**: Tuberculosis (combination), atypical mycobactaria, meningitis
  * **Adverse effect**: Orange-color urine
* **Ethambutol**
  * **Drug**: Ethambutol
  * **Mechanism**: Inhibit arabinosyl transfarase
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Visual disturbance
* **Pyrazinamide**
  * **Drug**: Pyrazinamide
  * **Indication**: Tuberculosis (combination)
  * **Adverse effect**: Hepatotoxicity
* **Dapsone**
  * **Drug**: Dapsone
  * **Mechanism**: Inhibit dihydropteroate synthase
  * **Indication**: Leprosy, pneumocystis pneumonia
  * **Adverse effect**: Hemolysis, methemoglobinemia
{: .notice--info}

### Antifungal Drug / 抗真菌薬

* **Polyene**
  * **Drug**: Amphotericin B, nystatin
  * **Mechanism**: Bind to ergosterol, form pores
  * **Indication**: Various fungus, cryptococcal meningitis (with flucytosine)
  * **Adverse effect**: Infusion-related reactions, nephrotoxicity
* **Azoles**
  * **Drug**: Itraconazole, ketoconazole, miconazole, fluconazole, clotrimazole, voriconazole, isavuconazole, posaconazole
  * **Mechanism**: Inhibit ergosterol synthesis (inhibit lanosterol methylation)
  * **Indication**: Various fungus, cryptococcal meningitis (fluconazole)
  * **Adverse effect**: Hepatotoxicity
* **Echinocandins**
  * **Drug**: Caspofungin, micafungin, anidulafungin
  * **Mechanism**: Inhibit cell wall synthesis
  * **Indication**: Candida, aspergillus
* **Flucytosine**
  * **Drug**: Flucytosine
  * **Mechanism**: Inhibit nucleic acid synthesis (converted to 5-fluorauracil)
  * **Indication**: Cryptococcal meningitis (with amphotericin B)
  * **Adverse effect**: Bone marrow supression
* **Griseofulvin**
  * **Drug**: Griseofulvin
  * **Mechanism**: Prevents spindle formation
  * **Indication**: Dermatophyte
{: .notice--info}

### Antiviral Drug / 抗ウイルス薬

* **Antiherpetic drug**
  * **Drug**: Acyclovir, valacyclovir, famiciclovir / ganciclovir, valganciclovir / foscarnet / cidofovir
  * **Mechanism**: Inhbit DNA polymerase (acyclovir, valacyclovir, famiciclovir: activated by viral thymidine kinase)
  * **Indication**: HSV, VZV, EBV, CMV
  * **Adverse effect**: Nephrotoxicity, neurotoxicity, bone marrow suppression
* **Anti-influenza drug**
  * **Drug**: Amantadine, rimantadine / zanamivir, neltamivir / baloxavir marboxil
  * **Mechanism**: M2 protein inhibitor / neuraminidase inhibitor / PA protein inhibitor
  * **Indication**: Influenza, prophylaxis
  * **Adverse effect**: CNS effect, GI dysfunction
* **Anti-HCV durg (direct-acting antiviral)**
  * **Drug**: Glecaprevir, grazoprevir, paritaprevir, simeprevir / daclatasvir, elbasvir, ledipasvir, ombitasvir, pibrentasvir, velpatasvir / sofosbubir, dasabuvir
  * **Mechanism**: NS3/4A inhibitor, NS5A inhibitor, NS5B inhibitor
  * **Indication**: HCV
* **Anti-HBV drug**
  * **Drug**: Lamivudine, adefovir, entecavir, tenofovir / interferon alpha
  * **Mechanism**: Inhibit DNA polymerase
  * **Indication**: HBV
{: .notice--info}

### Antiretroviral Drug / 抗HIV薬

* **Nucleoside reverse transcriptase inhibitor**
  * **Drug**: Tenofovir, abacavir, zidovudine, emtricitabine, lamivudine, didanosine, stavudine
  * **Mechanism**: Competitively inhibit reverse transcriptase (require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: Leukopenia, neuropathy, pancreatitis
* **Nonnucleoside reverse transcriptase inhibitor**
  * **Drug**: Efavirenz, nevirapine, rilpivirine, etravirine, delavirdine
  * **Mechanism**: Noncompetitively inhibit reverse transcriptase (not require phosphorylation)
  * **Indication**: HIV
  * **Adverse effect**: GI dysfunction, skin reaction
* **Protease inhibitor**
  * **Drug**: Ritonavir, darunavir, atazanavir, lopinavir
  * **Mechanism**: Inhibit polyprotein cleavage
  * **Indication**: HIV
  * **Adverse effect**: Hyperglycemia, hyparlipidemia lipodystrophy
* **Integrase inhibitor**
  * **Drug**: Raltegravir, elvitegravir, dolutegravir bictegravir.
  * **Mechanism**: Prevent viral DNA integration
  * **Indication**: HIV
* **Fusion inhibitor**
  * **Drug**: Enfuvirtida
  * **Mechanism**: Block viral entry (bind gp41)
  * **Indication**: HIV
* **CCR5 antagonist**
  * **Drug**: Maraviroc
  * **Mechanism**: Block viral entry (bind CCR5)
  * **Indication**: HIV
{: .notice--info}

### Antiparasitic Drug / 抗寄生虫薬

* **Anti-malaria drug**
  * **Drug**: Cloroquine, primaquine, quinine, atovaquone, artemether, mefloquine
  * **Indication**: Plasmodium vivax/ovale (chloroquine, primaquine), Plasmodium malaria (chloroquine), Plasmodium falciparum (quinine, atovaquone, artemther, mefloquine)
* **Anti-protozoa drug**
  * **Drug**: Metronidazole, stibogluconate sodium, nifurtimox, suramin
  * **Indication**: Entamoeba & Giardia & Trichomonas (metronidazole), Leishmania (stibogluconate sodium), trypanosoma (nifurtimox, suramin)
* **Anti-metazoa drug**
  * **Drug**: Albendazole, pyrantel pamoate, ivermectin, diethylcarbamazine, praziquantel, 
  * **Indication**: Nematode (albendazole, pyrantel pamoate, ivermectin), filaria (diethylcarbamazine), trematode & cestode (praziquantel)
{: .notice--info} -->

<!-- 

## Gram-Positive Bacterial Infection / グラム陽性菌感染症

### Staphylococcus Aureus Infection / 黄色ブドウ球菌感染症
### Staphylococcus Epidermidis Infection / 表皮ブドウ球菌感染症
### Streptococcus Pyogenes Infection / 化膿レンサ球菌感染症
### Streptococcus Agalactiae Infection / B群レンサ球菌感染症
### Streptococcus Pneumoniae Infection / 肺炎球菌感染症
### Viridans Streptococci Infection / 緑色レンサ球菌感染症
### Enterococcus Infection / 腸球菌感染症
### Diphtheria / ジフテリア
### Listeriosis / リステリア症
### Anthrax / 炭疽
### Botulism / ボツリヌス症
### Tetanus / 破傷風
### Clostridium Perfringens Infection / ウェルシュ菌感染症
### Clostridioides Difficile Infection / ディフィシル菌感染症
### Non-Sporeforming Anaerobe Infection / 無芽胞嫌気性菌感染症

## Gram-Negative Bacterial Infection / グラム陰性菌感染症

### Escherichia Coli Infection / 大腸菌感染症
### Shigellosis / 細菌性赤痢
### Typhoid Fever / 腸チフス
### Salmonellosis / サルモネラ症
### Plague / ペスト
### Yersinia Enterocolitica Infection / エルシニア感染症
### Klebsiella Pneumoniae Infection / クレブシエラ感染症
### Serratia Marcescens Infection / セラチア感染症
### Cholera / コレラ
### Vibrio Parahaemolyticus Infection / 腸炎ビブリオ感染症
### Vibrio Vulnificus Infection / バルニフィカス菌感染症
### Campylobacter Jejuni Infection / カンピロバクター感染症
### Helicobacter Pylori Infection / ピロリ菌感染症
### Haemophilus Influenzae Infection / インフルエンザ菌感染症
### Pertussis / 百日咳
### Pseudomonas Aeruginosa Infection / 緑膿菌感染症
### Acinetobacter Baumannii Infection / アシネトバクター感染症
### Legionellosis / レジオネラ症
### Brucellosis / ブルセラ症
### Tularemia / 野兎病
### Cat-Scratch Disease / ねこひっかき病
### Neisseria Gonorrhoeae Infection / 淋菌感染症
### Neisseria Meningitidis Infection / 髄膜炎菌感染症
### Moraxella Catarrhalis Infection / モラクセラ感染症

## Other Bacterial Infection / その他の細菌感染症

### Actinomycosis / 放線菌症
### Nocardiosis / ノカルジア症
### Tuberculosis / 結核
### Nontuberculous Mycobacteriosis / 非結核性抗酸菌症
### Leprosy / Hansen病
### Syphilis / 梅毒
### Borreliosis / ボレリア症
### Leptospirosis / レプトスピラ症
### Chlamydia Infection / クラミジア感染症
### Mycoplasma Infection / マイコプラズマ感染症
### Rickettsia Infection / リケッチア感染症

## DNA Viral Infection / DNAウイルス感染症

### Herpes Simplex Virus Infection / 単純ヘルペスウイルス感染症
### Varicella-Zoster Virus Infection / 水痘帯状疱疹ウイルス感染症
### Epstein-Barr Virus Infection / EBウイルス感染症
### Cytomegalovirus Infection / サイトメガロウイルス感染症
### Human Herpesvirus 6 & 7 Infection / ヒトヘルペスウイルス感染症
### Human Papillomavirus Infection / ヒトパピローマウイルス感染症
### Poxvirus Infection / ポックスウイルス感染症
### Parvovirus Infection / パルボウイルス感染症
### Adenovirus Infection / アデノウイルス感染症
### Hepatitis B / B型肝炎

## RNA Viral Infection / RNAウイルス感染症

### Influenza / インフルエンザ
### COVID-19 / 新型コロナウイルス感染症
### SARS / 重症急性呼吸器症候群
### MERS / 中東呼吸器症候群
### Norovirus Infection / ノロウイルス感染症
### Rotavirus Infection / ロタウイルス感染症
### Enterovirus Infection / エンテロウイルス感染症
### Measles Virus Infection / 麻疹ウイルス感染症
### Rubella Virus Infection / 風疹ウイルス感染症
### Mumps Virus Infection / ムンプスウイルス感染症
### Japanese Encephalitis / 日本脳炎
### West Nile Encephalitis / ウエストナイル脳炎
### Rabies / 狂犬病
### Dengue Fever / デング熱
### Chikungunya Fever / チクングニア熱
### Zika Fever / ジカ熱
### Ebola Hemorrhagic Fever / エボラ出血熱
### SFTS / 重症熱性血小板減少症候群
### HIV Infection / HIV感染症
### HTLV-1 Infection / HTLV-1感染症
### Hepatitis A / A型肝炎
### Hepatitis C / C型肝炎
### Hepatitis D / D型肝炎
### Hepatitis E / E型肝炎

## Fungal Infection / 真菌感染症

### Candidiasis / カンジダ症
### Aspergillosis / アスペルギルス症
### Mucormycosis / ムーコル症
### Cryptococcosis / クリプトコックス症
### Pneumocystis Infection / ニューモシスチス感染症
### Histoplasmosis / ヒストプラスマ症
### Coccidioidomycosis / コクシジオイデス症
### Blastomycosis / ブラストミセス症

## Protozoal Infection / 原虫感染症

### Amebiasis / アメーバ赤痢
### Giardiasis / ランブル鞭毛虫症
### Cryptosporidiosis / クリプトスポリジウム症
### Malaria / マラリア
### Babesiosis / バベシア症
### Toxoplasmosis / トキソプラズマ症
### Leishmaniasis / リーシュマニア症
### African Sleeping Sickness / アフリカ睡眠病
### Chagas Disease / シャーガス病
### Trichomoniasis / トリコモナス症

## Helminthic Infection / 蠕虫感染症

### Ascariasis / 回虫症
### Enterobiasis / 蟯虫症
### Trichuriasis / 鞭虫症
### Hookworm Infection / 鉤虫症
### Strongyloidiasis / 糞線虫症
### Anisakiasis / アニサキス
### Filariasis / フィラリア症
### Onchocerciasis / オンコセルカ症
### Loiasis / ロア糸状虫症
### Gnathostomiasis / 顎口虫症
### Angiostrongyliasis / 広東住血線虫症
### Trichinellosis / 旋毛虫症
### Schistosomiasis / 住血吸虫症
### Clonorchiasis / 肝吸虫症
### Metagonimiasis / 横川吸虫症
### Paragonimiasis / 肺吸虫症
### Diphyllobothriasis / 裂頭条虫症
### Taeniasis Saginata / 無鉤条虫症
### Taeniasis Solium / 有鉤条虫症
### Echinococcosis / 包虫症

-->

# Neurology / 神経科

## Introduction / 総論

## Cerebrovascular Disorder / 脳血管障害

### Cerebral Infarction / 脳梗塞

* **Overview**
  * Thrombus or embolus obstruct cerebral artery, ischemia and necrosis in the supplied areas, various neurological symptoms and permanent disabilities 
  * [Atherothrombotic infarction] Thrombus forms due to atherosclerosis of carotid or cerebral arteries; hypertension, diabetes, dyslipidemia, smoking, and heavy drinking increase the risk
  * [Cardioembolic infarction] Embolus forms in heart due to heart diseases (atrial fibrillation, valvular heart disease, myocardial infarction)
  * [Lacunar infarction] Lipohyalinosis (blood vessel degeneration due to prolonged hypertension) or microatheroma block small penetrating arteries (to basal ganglia, internal capsule, thalamus)
* **Presentation**
  * **Contralateral hemiplegia, sensory disturbances, dysarthria**: Damage to primary motor or somatosensory cortex
  * **Aphasia, agnosia**: Damage to association cortex
  * **Consciousness disorder**: Widespread cortical damage
  * **Dizziness, nausea, vomiting, cerebellar ataxia, dysarthria (in case of cerebellar infarction)**: Damage to cerebellar balancing and coordinating functions
  * **Temperature and pain sensation impairment of ipsilateral face and contralateral limbs, nystagmus, hoarseness, dysarthria (in case of brainstem infarction, particularly Wallenberg syndrome)**: Damage to spinothalamic tract and cranial nerve nucleus at lateral medulla
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance, with proprioception preserved (in case of spinal cord infarction, particularly anterior spinal artery syndrome)**
  * **[Atherothrombotic infarction] Occur at rest (often sleeping) and gradually worsen; sometimes preceded by transient ischemic attack**: Stasis of blood flow promotes thrombus formation, thrombus gradually enlarge and progressively block the blood flow
  * **[Cardioembolic infarction] Occur suddenly during activity and develop rapidly, often with large infarct area and severe symptoms**: Increased blood flow during activity dislodge the thrombus,  thrombus rapidly block a major cerebral artery
  * **[Lacunar infarction] Mild motor disturbances, sensory disturbances or dysarthria, without cortical symptoms**: Blockage of small penetrating artery resulting in small infarction area in deep brain
* **Examination**
  * **[CT] No obvious abnormalities in hyperacute phase, low-density region in acute and chronic phase**: No enough structural changes in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[MRI] High-signal on DWI in hyperacute phase, high signal on T2 and FLAIR in acute and chronic phase**: Water accumulate in cells with restricted diffusion in hyperacute phase, edema in acute phase, liquefactive necrosis in chronic phase
  * **[CTA, MRA, cerebral angiography] Vascular stenosis or occlusion**
* **Management**
  * **[Acute phase] Respiration management (intubation as needed), circulation management (avoid aggressively lowering BP), metabolism management (fluid, glucose)**: Control respiration, circulation, metabolism
  * **[Acute phase] Thrombolytics (rt-PA) or thrombectomy**: Activate plasminogen and dissolve clot, or directly remove clot endovascularly
  * **[Acute phase] Antiplatelet drugs (ozagrel, aspirin) and anticoagulants (heparin, argatroban), neuroprotective drugs (edaravone), anti-cerebral adema drugs (glycerol)**: Prevent thrombus enlargement, prevent free radical damage, prevent brain herniation
  * **[Chronic phase] Control hypertension, diabetes, dyslipidemia, obesity**: Control risk factors
  * **[Chronic phase] Antiplatelet drugs (clopidogrel, cilostazol, aspirin) for atherothrombotic and lacunar infarction, anticoagulants (dabigatran, rivaroxaban, warfarin) for cardioembolic infarction**: Prevent thrombus or embolus formation
  * **[Chronic phase] Rehabilitation**
{: .notice--info}

### Transient Ischemic Attack / 一過性脳虚血発作

* **Overview**
  * Thrombus or embolus obstruct peripheral arteries, transient neurological symptoms, thrombus dissolves and vessels reopen soon after, may precede cerebral infarction due to larger thrombus formation
* **Presentation**
  * **Temporary loss of vision, weakness and hemiplegia, numbness, aphasia (resolve within 2 ~ 15 minutes)**: Temporary ischemia of eye, motor cortex, sensory cortex, language cortex
  * **May develop to cerebral infarction**
* **Examination**
  * **[CT, MRI] No findings of cerebral infarction**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), anticoagulants (dabigatran, rivaroxaban, warfarin), carotid edarterectomy or carotid artery stenting, control risk factors**: Prevent thrombus or embolus formation
{: .notice--info}

### Carotid Artery Stenosis / 頸動脈狭窄症

* **Overview**
  * Narrowing of carotid artery due to atherosclerosis, may lead to TIA or cerebral infarction due to dislodged thrombus
* **Presentation**
  * **Asymptomatic**
  * **May cause TIA or cerebral infarction**
* **Examination**
  * **[Carotid ultrasound] Stenosis of internal carotid artery**
  * **[MRA, CTA, cerebral angiography] Stenosis of internal carotid artery**
* **Management**
  * **[Preventive] Antiplatelet drugs (clopidogrel, cilostazol, aspirin), control hypertension, diabetes, dyslipidemia**: Prevent thrombus formation
  * **[Surgical] Carotid edarterectomy, carotid artery stenting**: Directly remove plaque or prevent plaque breaking off
{: .notice--info}

### Cerebral Hemorrhage / 脳出血

* **Overview**
  * Prolonged hypertension weakens vessels walls, leading to rupture and bleeding
  * [Putaminal hemorrhage] Rupture of lenticulostriate artery
  * [Thalamic hemorrhage] Rupture of thalamoperforating or thalamogeniculate artery
  * [Brainstem hemorrhage] Rupture of pontine arteries
  * [Cerebellar hemorrhage] Rupture of superior cerebellar artery
  * [Subcortical hemorrhage] Rupture of cortical branches
* **Presentation**
  * **Headache, impaired consciousness**: Increased intracranial pressure lead to pain and brain herniation
  * **Contralateral hemiplegia, sensory disturbances**: Damage to descending or ascending fibers in internal capsule
  * **[Putaminal hemorrhage] Conjugate deviation of eyes towards affected side**: Damage to corticobulbar fibers to contralateral PPRF (horizontal gaze center)
  * **[Thalamic hemorrhage] Downward and inward deviation of eyes**: Damage to superior colliculus (vertical gaze center)
  * **[Brainstem hemorrhage] Respiratory distress,quadriplegia, fixed midline eyes, pinpoint pupils**: Damage to respiratory center, bilateral corticospinal tract, PPRF and superior colliculus, sympathetic tract
  * **[Cerebellar hemorrhage] Rotational vertigo and repeated vomiting, standing and walking difficulty**: Damage to cerebellar balancing function and coordination function
  * **[Subcortical hemorrhage] Motor disturbances, sensory disturbances, visual field defects, sensory aphasia**: Damage to frontal lobe, parietal lobe, occipital lobe, temporal lobe
* **Examination**
  * **[CT] High-density region**: Fresh blood has higher density
* **Management**
  * **[Clear consciousness] Respiration management (intubation as needed),  circulation management (systolic pressure < 140 mmHg), metabolism management (fluid), anti-cerebral adema drugs (glycerol, mannitol)**: Control respiration, circulation, metabolism, cerebral edema
  * **[Impaired consciousness] Hematoma removal surgery, ventricular drainage**: Relieve brain herniation due to hematoma or hydrocephalus
  * **[Chronic phase] Control hypertension, rehabilitation**
{: .notice--info}

### Arteriovenous Malformation / 脳動静脈奇形

* **Overview**
  * Congenital cerebrovascular abnormality where arteries and veins directly connect without capillaries, result in a cluster of dilated and tortuous vessels (nidus), may lead to cerebral hemorrhage and secondary subarachnoid hemorrhage due to rupture
  * More common in children and young adults
* **Presentation**
  * **Headache, seizures, progressive hemiplegia**: Abnormal connection bypass capillaries and cause ischemia
  * **Motor disturbance, sensory disturbance, bladder and rectal disturbance (in case of spinal AVM)**
  * **May cause cerebral hemorrhage and secondary subarachnoid hemorrhage**
* **Examination**
  * **[Cerebral angiography, MRA] Cluster of dilated and tortuous vessels**
  * **[MRI] Multiple flow void (no signal) region**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Hemorrhage or symptomatic] Resection of nidus, embolization of nidus, gamma knife**: Prevent hemorrhage
  * **[Non-hemorrhage] Anticonvulsants**: Symptomatic treatment
{: .notice--info}

### Subarachnoid Hemorrhage / くも膜下出血

* **Overview**
  * Bleeding into subarachnoid space due to rupture of vascular lesions, underlying diseases include cerebral aneurysm (80%) and arteriovenous malformations
* **Presentation**
  * **Sudden severe pain**: Increased intracranial pressure trigger pain
  * **Nausea, vomiting, impaired consciousness**: Increased intracranial pressure irritates brainstem
  * **Neck stiffness, Kernig sign, Brudzinski sign, positive neck flexion test**: Blood in subarachnoid space irritates meninges
  * **[Complication] Rebleeding**: Dislodge of the initial clot due to fluctuation of blood pressure
  * **[Complication] Cerebral vasospasm**: Blood breakdown products irritate and trigger contractions of vessels
  * **[Complication] Normal pressure hydrocephalus**: Blood breakdown products obstruct CSF absorption pathway
* **Examination**
  * **[CT] Star-shaped high-density area around suprasellar region**: Fresh blood pooling in subarachnoid space (which has star-shaped anatomy around suprasellar region)
  * **[MRI] High signal on FLAIR**: FLAIR suppress CSF signal but highlight abnormal fluid (blood)
  * **[CSF analysis] Blood-stained CSF or xanthochromia (yellowish CSF)**: RBC or bilirubin in CSF
  * **[DSA (4-vessel study), MRA, 3D-CTA] Cerebral aneurysm (preoperative)**
* **Management**
  * **[Preoperative] Blood pressure management (antihypertensive drugs), intracranial pressure management (anti-cerebral edema drugs), pain relief and sedation (diazepam, pentazocine)**: Prevent rebleeding and brain herniation
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: Prevent rebleeding
  * **[Postoperative] Vasodilator (fasudil), antiplatelet drug (ozagrel)**: Prevent vasospasm
{: .notice--info}

### Cerebral Aneurysm / 脳動脈瘤

* **Overview**
  * Bulge in brain vessels (particularly in branching points) due to congenital defects in tunica media and acquired factors such as hypertension and arteriosclerosis; usually asymptomatic but may lead to subarachnoid hemorrhage due to rupture
  * More common in middle age adults
* **Presentation**
  * **Asymptomatic in most cases**
  * **Mydriasis, diplopia, ptosis**: Compression of oculomotor nerve by aneurysm
  * **Vision and visual field defects**: Compression of optic nerve by aneurysm
  * **May cause subarchnoid hemorrhage** 
* **Examination**
  * **[MRA, 3D-CTA, DSA] Cerebral aneurysm**
* **Management**
  * **[Observation]**: If asymptomatic 
  * **[Surgical] Aneurysm neck clipping, aneurysm coil embolization**: If symptomatic or high risk of rupture
{: .notice--info}

### Moyamoya Disease / もやもや病

* **Overview**
  * Narrowing or occlusion of arteries in circle of Willis lead to ischemia, fragility of compensating collateral circulation lead to hemorrhage
  * More common in children under 10s and adults in 30s ~ 40s
* **Presentation**
  * **[Childhood] Temporary hemiplegia, sensory disturbances, altered consciousness, seizures after cooling hot food by blowing, playing wind instruments, intense crying**: Hypoventilation cause decreased CO2 levels, lead to cerebral vasoconstriction and ischemia
  * **[Adulthood] May lead to cerebral hemorrhage**
* **Examination**
  * **[DSA, MRA] Narrowing or occlusion near terminal portion of internal carotid artery, presence of moyamoya vessles near basal ganglia**
  * **[MRI] Punctate or linear flow void (no signal) region near basal ganglia**: MRI cannot capture fast-moving blood in abnormal vessels
* **Management**
  * **[Surgical] STA-MCA bypass**: Revascularization by connecting superficial temporal artery and middle cerebral artery
  * **[Medical] Antiplatelet drugs, anticonvulsants**: Infarction prevention and symptomatic treatment 
{: .notice--info}

### Carotid-Cavernous Fistula / 内頸動脈-海綿静脈洞瘻

* **Overview**
  * Arteriovenous fistula forms between internal carotid artery and cavernous sinus due to trauma or rupture of aneurysm, lead to increased pressure in cavernous sinus and ophthalmic veins
  * [Dural arteriovenous fistula] Arteriovenous fistula can also form in transverse sinus and sigmoid sinus
* **Presentation**
  * **Pulsatile exophthalmos, conjunctival congestion and edema**: Increased pressure in ophthalmic veins in a pulsatile fashion 
  * **Pulsatile bruit in orbital region, extraocular muscle paralysis**: Increased pressure in cavernous sinus in a pulsatile fashion 
* **Examination**
  * **[Cerebral angiography ] Visualization of cavernous sinus during arterial phase**: Arterial blood flows directly into cavernous sinus
* **Management**
  * **Endovascular embolization using coil**: Occlusion of the fistula
{: .notice--info}

### Sinus Thrombosis / 静脈洞血栓症

* **Overview**
  * Thrombus forms in venous sinus and obstructs blood return, due to dural arteriovenous fistula or hypercoagulability
* **Presentation**
  * **Headache, vomiting**: Increased intracranial pressure
* **Examination**
  * **[MRV] Narrowing or occlusion of venous sinus**
* **Management**
  * **Anticoagulants (heparin)**: Prevent further thrombus formation
{: .notice--info}

### Hypertensive Encephalopathy / 高血圧性脳症

* **Overview**
  * Sudden or severe increase in blood pressure impairs brain’s autoregulation and blood-brain barrier, lead to cerebral edema and neurological symptoms 
* **Presentation**
  * **Headache, nausea, vomiting, consciousness disturbances**: Increased intracranial pressure
* **Examination**
  * **[MRI] High signal in localized area**: Edema
  * **[CT] Low-density in localized area**: Edema
* **Management**
  * **Calcium channel blockers (nicardipine), anti-cerebral edema drugs (glycerol, mannitol)**: Reduce blood pressure, relieve cerebral edema
{: .notice--info}

## Dementia / 認知症

### Alzheimer’s Dementia / Alzheimer型認知症

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of amyloid β and phosphorylated tau protein, leading to cognitive impairment
  * Common in elderly individuals, most common type of dementia
  * Pathology shows cerebral atrophy grossly, senile plaques and neurofibrillary tangles microscopically 
* **Presentation**
  * **[Core symptoms] Memory impairment, disorientation, executive dysfunction, aphasia, apraxia, agnosia**: Degeneration of cerebral cortex, mainly temporal lobe (hippocampus) and parietal lobe 
  * **[BPSD] Insomnia, hallucinations/delusions, depressive states, anxiety/agitation, excitement/violence, unclean behavior, wandering, pica/overeating, dependency**: Disruption of normal brain functions
* **Examination**
  * **[Cognitive function test] HDS-R score <= 20, MMSE <= 23**: Cognitive impairment
  * **[CT, MRI] Atrophy, mainly temporal lobe and hippocampus**: Degeneration of temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly temporal lobe and parietal lobe**: Reduced neuronal activity leads to reduced blood flow
* **Management**
  * **Cholinesterase inhibitor (donepezil, galantamine, rivastigmine)**: Reduce breakdown and increase level of acetylcholine, improve signal transduction
  * **NMDA receptor antagonist (memantin)**: Inhibit excessive glutamate activity, reduce neuronal damage 
{: .notice--info}

### Dementia With Lewy Bodies / Lewy小体型認知症

* **Overview**
  * Degeneration of cerebral cortex due to accumulation of α-synuclein, leading to cognitive impairment and Parkinsonism
Pathology shows Lewy bodies
* **Presentation**
  * **Cognitive impairment, visual hallucinations (with daily or weekly fluctuation)**: Degeneration of cerebral cortex, mainly occipital lobe
  * **Parkinsonism, REM sleep behavior disorder**: Degeneration of basal ganglia and brainstem
* **Examination**
  * **[SPECT, PET] Reduced blood flow, mainly occipital lobe**: Degeneration of occipital lobe
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fiber
  * **[Dopamine reuptake test] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Cholinesterase inhibitor (donepezil)**: For cognitive impairment
  * **Levodopa**: For Parkinsonism
  * **Benzodiazepine (clonazepam)**: For REM sleep behavior disorder
{: .notice--info}

### Frontotemporal Dementia / 前頭側頭型認知症

* **Overview**
  * Degeneration of cerebral cortex (mainly frontal and temporal lobe), leading to cognitive impairment, personality changes and behavioral abnormalities 
* **Presentation**
  * **Decreased spontaneity, emotional blunting, disinhibition, stereotyped behaviors**: Degeneration of cerebral cortex, mainly frontal lobe and temporal lobe 
* **Examination**
  * **[CT, MRI] Atrophy, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
  * **[SPECT, PET] Reduced blood flow, mainly frontal lobe and temporal lobe**: Degeneration of frontal lobe and temporal lobe
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Vascular Dementia / 血管性認知症

* **Overview**
  * Cerebrovascular diseases damage the brain, leading to cognitive impairment
* **Presentation**
  * **Gradual and patchy decline in cognitive function**: Gradual and partial damage to cerebral cortex
  * **Motor and sensory disturbances**: Other symptoms of cerebral infarction or hemorrhage
* **Examination**
  * **[CT, MRI] Cerebral infarction or hemorrhage**
* **Management**
  * **Control hypertension, antiplatelet drugs, anticoagulants**: Prevent relapse of infarction
{: .notice--info}

## Neurodegenerative Disorder / 神経変性疾患

### Parkinson’s Disease / Parkinson病

* **Overview**
  * Degeneration of dopamine neuron in substantia nigra pars compacta lead to dopamine deficiency, the direct pathway of basal ganglia (striatum - globus pallidus internum - thalamus) cannot be excited and making movement difficult
  * More common in middle-aged to elderly individuals 
  * Pathology reveals loss of neuromelanin-containing cells in substantia nigra and appearance of Lewy bodies in nerve cells (due to accumulation of α-synuclein)
* **Presentation**
  * **Akinesia (slow movement, difficulty initiating walking and short-step gait, masked face)**: Dopamine depletion disrupts movement control
  * **Resting tremor  (pill-rolling tremor, tapping tremor)**: Dopamine depletion disrupts movement control
  * **Muscle rigidity (cogwheel or lead-pipe)**: Dopamine depletion disrupts muscle tone control
  * **Postural instability (increased tendency to fall when pushed)**: Dopamine depletion disrupts balance maintenance 
  * **Depression, dementia, sleep disorder**: Dopamine depletion disrupts mood and cognition
  * **Orthostatic hypotension, urinary dysfunction, chronic constipation**: Dopamine depletion disrupts autonomic system
* **Examination**
  * **[CT, MRI] No specific findings**
  * **[MIBG myocardial scintigraphy] Decreased uptake**: Degeneration of postganglionic sympathetic nerve fibers
  * **[Dopamine transporter imaging] Loss of dopamine neuron in basal ganglia**
* **Management**
  * **Dopamine precursor (levodopa) + dopamine decarboxylase inhibitor (carbidopa)**: Levodopa cross blood-brain barrier and convert to dopamine (carbidopa inhibit the conversion in peripheral tissue)
  * **Dopamine agonist (bromocriptine, pergolide, cabergoline, pramipexole, ropinirole, rotigotine, apomorphine)**: Stimulate dopamine receptor
  * **Anticholinergic drugs (trihexyphenidyl, biperiden, prophenamine)**: Balance acetylcholine and dopamine level
  * **Dopamine release promoter (amantadine)**: Increase dopamine release
  * **Monoamine oxidase B inhibitor (selegiline, rasagiline)**: Inhibit breakdown of dopamine
  * **COMT inhibitor (Entacapone)**: Inhibit breakdown of levodopa
  * **Deep brain stimulation (subthalamic nucleus or globus pallidus)**: Modulate abnormal neural activity caused by dopamine deficiency 
{: .notice--info}

### Progressive Supranuclear Palsy / 進行性核上性麻痺

* **Overview**
  * Degeneration of basal ganglia and brainstem due to abnormal accumulation of tau protein
* **Presentation**
  * **Increased neck muscle tone, akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
  * **Vertical gaze palsy, speech and swallowing impairment**: Degeneration of brain stem
  * **Mental disturbances**: Degeneration of frontal lobe
* **Examination**
  * **[CT, MRI] Atrophy of midbrain tegmentum (hummingbird sign)**
* **Management**
  * **No established treatment, similar to medication for Parkinson’s disease**: Limited response
{: .notice--info}

### Corticobasal Degeneration / 大脳皮質基底核変性症

* **Overview**
  * Degeneration of cerebral cortex and basal ganglia due to abnormal accumulation of tau protein
* **Presentation**
  * **Motor clumsiness, apraxia, alien hand syndrome, dementia, involuntary movements (asymmetry between two sides)**: Degeneration of cerebral cortex
  * **Akinesia, muscle rigidity, postural instability, (resting tremor is absent)**: Degeneration of basal ganglia
* **Examination**
  * **[CT, MRI] Asymmetric cortical atrophy**
* **Management**
  * **No established treatment, similar to medication for Parkinson’s disease**: Limited response
{: .notice--info}

### Huntington’s Disease / Huntington病

* **Overview**
  * Degeneration of striatum lead to overactivity of dopaminergic neurons, causing involuntary movements
Autosomal dominant inheritance, due to abnormal expansion of CAG repeats
* **Presentation**
  * **Rapid involuntary movements of limbs**: Degeneration of striatum disruptions inhibition of involuntary movements
  * **Personality change, dementia**: Degeneration of cerebral cortex
* **Examination**
  * **[CT, MRI] Atrophy of caudate nucleus, enlargement of anterior horns of lateral ventricles**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Tetrabenazine**: For involuntary movements
  * **Antipsychotics (haloperidol)**: For psychiatric symptoms
{: .notice--info}

### Amyotrophic Lateral Sclerosis / 筋萎縮性側索硬化症

* **Overview**: 
  * Degeneration of upper and lower motor neurons leads to progressive muscular atrophy; mostly sporadic but sometimes hereditary 
  * More common in middle-aged to elderly individuals 
  * Pathology shows atrophy of pyramidal tract and anterior horn, with TDP-43 positive inclusions
* **Presentation**
  * **Muscle weakness, muscle atrophy, fasciculations**: Degeneration of lower motor neurons lead to reduced stimulation on muscles
  * **Increased tendon reflexes, positive Babinski sign**: Degeneration of upper motor neurons lead to reduced inhibition on lower motor neurons
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves lead to bulbar palsy
  * **No eye movement disorders, sensory impairments, bladder or rectal dysfunction, pressure sores**: Cranial nerves III IV VI, sensory neurons, autonomic neurons are spared
* **Examination**
  * **[EMG] Denervation potentials at rest**: Denervation from lower motor neurons leads to spontaneous electrical activity
  * **[EMG] High-amplitude potentials during voluntary contraction**: Degeneration of lower motor neurons leads to formation of larger motor units by remaining neurons
  * **[Muscle biopsy] Grouped atrophy**: Denervation of motor units
* **Management**
  * **No cure**: Progress to requiring mechanical ventilation or death in 3~5 years
  * **[Medication] Riluzole, edaravone**: Protect neurons by reducing glutamate activity or scavenging free radicals
{: .notice--info}

### Spinal Muscular Atrophy / 脊髄性筋萎縮症

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; autosomal recessive inheritance
  * Type I onset at birth and die within one year, type III onset at 2~18 years and have good prognosis
* **Presentation**
  * **Muscle weakness (floppy infant, Gowers’ sign), fasciculations, absent tendon reflexes**: Degeneration of lower motor neurons cause reduced stimulation on muscles
* **Examination**
  * **[Genetic test] SMN gene mutation**
* **Management**
  * **Symptomatic treatment**: Type I die within one year, type III and IV have good prognosis
{: .notice--info}

### Bulbospinal Muscular Atrophy / 球脊髄性筋萎縮症

* **Overview**
  * Degeneration of lower motor neurons leads to progressive muscular atrophy; X-linked recessive inheritance, due to abnormal expansion of CAG repeats in androgen receptor gene
* **Presentation**
  * **Muscle weakness, muscle atrophy (primarily proximal muscles), fasciculations, tremors**: Degeneration of lower motor neurons cause reduced stimulation on muscles
  * **Dysphagia, dysarthria, tongue atrophy**: Degeneration of cranial nerves cause bulbar palsy
  * **Gynecomastia, impotence, testicular atrophy**: Abnormal androgen receptor lead to reduced sensitivity to androgen
* **Examination**
  * **[Genetic test] Abnormal expansion of CAG repeats**
* **Management**
  * **Symptomatic treatment**: Prognosis depends on CAG repeats number
{: .notice--info}

### Multiple System Atrophy / 多系統萎縮症

* **Overview**
  * Degeneration of olivo-ponto-cerebellar system, striatonigral system, and autonomic nervous system; sporadic
  * More common in middle-aged to elderly individuals 
  * Pathology shows glial cytoplasmic inclusion (due to accumulation of α-synuclein)
  * [MSA-C] Cerebellar ataxia as predominant early symptom, but other symptoms present later
  * [MSA-P] Parkinsonism as predominant early symptom, but other symptoms present later
  * [Shy-Drager syndrome] Autonomic dysfunction as predominant early symptom, but other symptoms present later
* **Presentation**
  * **[Cerebellar ataxia] Truncal ataxia (staggering gait), limb coordination problems (abnormal finger-to-nose test), dysarthria**: Degeneration of olivo-ponto-cerebellar system
  * **[Parkinsonism] Bradykinesia, muscle rigidity, shuffling gait (resting tremor are rare)**: Degeneration of striatonigral system
  * **[Autonomic dysfunction] Orthostatic hypotension, bladder and rectal dysfunction, erectile dysfunction, sweating abnormalities, horner syndrome**: Degeneration of autonomic nervous system
* **Examination**
  * **[CT, MRI] Atrophy of cerebellum and brainstem, cross sign in pons**: Degeneration of olivo-ponto-cerebellar system, degeneration of transverse and longitudinal pontocerebellar fibers
  * **[CT, MRI] Atrophy of putamen, linear area of high-signal on lateral side of putamen**: Degeneration of striatonigral system, gliosis of lateral side of putamen
* **Management**
  * **[Cerebellar ataxia] TRH analog (protirelin, taltirelin)**: Stimulate neurotransmission and enhance motor control
  * **[Parkinsonism] Dopamine precursor (levodopa)**: Converted to dopamine and alleviate Parkinsonism
  * **[Autonomic dysfunction] Alpha-agonists (midodrine, droxidopa), alpha-blockers**: For orthostatic hypotension or urinary retention 
{: .notice--info}

### Spinocerebellar Ataxia / 脊髄小脳失調症

* **Overview**
  * Degeneration of cerebellum or spinal cord; hereditary
  * [SCA-3] Abnormal expansion of CAG repeats in ataxia-3 gene, autosomal dominant
  * [SCA-6] Abnormal expansion of CAG repeats in CACNA1A gene, autosomal dominant
  * [Dentato-rubro-pallido-luysian atrophy] Abnormal expansion of atrophin-1 gene, autosomal dominant
  * [Friedreich ataxia] Abnormal expansion of GAA repeats in frataxin genes, autosomal recessive
* **Presentation**
  * **Cerebellar ataxia, startled expression (SCA-3)**: Degeneration of cerebellum 
  * **Spinal ataxia, deep sensory loss (Friedreich ataxia)**: Degeneration of spinal cord
* **Examination**
  * **[CT. MRI] Degeneration of cerebellum and spinal cord**
* **Management**
  * **Symptomatic treatment**
{: .notice--info}

### Wernicke Encephalopathy / Wernicke脳症

* **Overview**
  * Vitamin B1 deficiency (chronic alcoholism, malnutrition, inappropriate IV infusion) damage neurons and cause necrosis (mainly around cerebral ventricles)
* **Presentation**
  * **Consciousness disturbances (somnolence, delirium)**: Impairment of thalamus
  * **Ocular movement disorders (abducens nerve palsy, nystagmus)**: Impairment of brainstem (cranial nerve nucleus)
  * **Cerebellar dysfunction (ataxic gait)**: Impairment of cerebellum 
  * **Korsakoff syndrome (memory impairment, confabulation, disorientation)**: Irreversible damage to brain if untreated
* **Examination**
  * **[MRI] High signal in third ventricle, cerebral aqueduct, fourth ventricle, mammillary body**: Neuronal damage around cerebral ventricles
  * **[Blood test] Vitamin B1 decrease**: Vitamin B1 deficiency
* **Management**
  * **Large intravenous administration of Vitamin B1**
  * **[Don’t] Glucose administration alone during Vitamin B1 deficiency is contraindicated**: Further consume Vitamin B12
{: .notice--info}

### Subacute Combined Degeneration of Spinal Cord / 亜急性脊髄連合変性症

* **Overview**
  * Vitamin B12 deficiency (total gastrectomy, autoimmune atrophic gastritis) cause degeneration of posterior column, lateral column and peripheral nerve
* **Presentation**
  * **Deep sensory impairment, positive Romberg’s sign**: Impairment of posterior column
  * **Increased tendon reflexes, positive Babinski sign, spastic paralysis**: Impairment of lateral column
  * **Numbness, muscle weakness**: Impairment of peripheral nerves
  * **Anemia, Hunter’s glossitis**: Impairment of DNA synthesis 
* **Examination**
  * **[Blood test] Megaloblastic anemia, vitamin B12 decrease, methylmalonic acid increase, homocysteine increase**: Vitamin B12 is crucial for DNA synthesis (RBC production), conversion of methylmalonyl-CoA to succinyl-CoA, conversion of homocysteine to methionine
  * **[MRI] High-signal in posterior column and lateral column**
* **Management**
  * **IV and oral administration of Vitamin B12**
  * **[Don’t] Folic acid administration alone is contraindicated**: Mask the neurological symptoms and further consume Vitamin B12
{: .notice--info}

## Demyelinating Disorder / 脱髄性疾患

### Multiple Sclerosis / 多発性硬化症

* **Overview**
  * Autoimmune-related Inflammatory demyelination throughout white matter of CNS (spatial dissemination), leading to various neurological symptoms that recur and remit (temporal dissemination); PNS usually spared
  * Relapsing-remitting type (more) characterized by relapse and remission at first and progress without remission later; primary progressive type (less) progress without remission from onset
  * More common in young women (autoimmune) and high latitude region
* **Presentation**
  * **Vision loss, central scotomas (recover in 1-2 weeks, relapse latter)**: Impairment of optic nerve (optic neuritis)
  * **Internuclear ophthalmoplegia**: Impairment of medial longitudinal fasciculus
  * **Ataxia, tremor, nystagmus, dysarthria**: Impairment of cerebellum
  * **Weakness of extremities, spasticity, hyperreflexia, clonus**: Impairment of motor pathway
  * **Numbness, electric shock-like sensation during neck movement (Lhermitte’s sign), trigeminal neuralgia**: Impairment of sensory pathway
  * **Bladder and bowel dysfunction**: Impairment of autonomic nervous system
* **Examination**
  * **[MRI] Multiple high-signal plaque lesion in brain and spinal cord**: Demyelination of CNS white matter
  * **[CSF analysis] Lymphocytes increased, IgG increased, oligoclonal band present, myelin binding protein present**: Autoimmune destruction of myelin in CNS
  * **Abnormal evoked potential (especially visual)**: Demyelination of the corresponding pathway
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Interferon-beta, glatiramer (MBP-mimicking peptide), natalizumab (anti-α4 integrin antibody), fingolimod (S1PR modulator)**: Immunomodulatory or immunosuppressive drugs
  * **[Symptomatic treatment] Muscle relaxant, anticonvulsant (gabapentin, pregabalin), anticholinergic drugs or alpha-blockers**: For spasticity, neuropathic pain, urinary symptoms
{: .notice--info}

### Neuromyelitis Optica / 視神経脊髄炎

* **Overview**
  * Anti-AQP4 autoantibody damage astrocytes, lead to inflammatory demyelination causing relapsing optic neuritis and myelitis
More common in middle age women (autoimmune)
* **Presentation**
  * **Vision loss, visual field defects**: Impairment of optic nerve (optic neuritis)
  * **Motor disturbances, sensory disturbances, bladder and bowel dysfunction**: Impairment of spinal cord (myelitis)
* **Examination**
  * **[MRI] High-signal lesion in brain and spinal cord (>3 vertebral segments)**: Demyelination of optic nerve and spinal cord
  * **[Blood] Anti-AQP4 antibody positive**: Autoimmune nature
* **Management**
  * **[Acute exacerbation] Steroid pulse therapy, plasmapheresis**: Suppress acute inflammation
  * **[Relapse prevention] Steroid, immunosuppressant, rituximab (anti -CD20 antibody)**
{: .notice--info}

### Acute Disseminated Encephalomyelitis / 急性散在性脳脊髄炎

* **Overview**
  * Inflammatory demyelination of throughout CNS (spatial dissemination) with acute and monophasic course (compared to multiple sclerosis), preceded by viral infection or vaccination (hypersensitivity)
* **Presentation**
  * **Fever, headache, vomiting (acute onset and rapid remission)**: Inflammation of brain
* **Examination**
  * **[Blood] WBC increase, ESR increase, CRP increase**: Inflammation
  * **[MRI] Scattered high-signal lesions in brain**: Disseminated demyelination of CNS
* **Management**
  * **Steroid pulse therapy, plasmapheresis, high-dose immunoglobulin therapy**: Suppress acute inflammation
{: .notice--info}

### Adrenoleukodystrophy / 副腎白質ジストロフィー

* **Overview**
  * X-linked recessive disorder, defects of peroxisome prevent breakdown of very long-chain fatty acids, which accumulate in white matter of brain (progressive demyelination) and adrenal gland (adrenal insufficiency)
* **Presentation**
  * **Personality and behavioral abnormalities (aggression), intellectual disability**: Impairment of commissural fibers of brain
  * **Gait disturbances (ataxic gait)**: Impairment of spinal cord
  * **Vision and hearing impairment**: Impairment of visual and auditory pathway
* **Examination**
  * **[Blood] Cortisol decrease, very long-chain fatty acids increase**: Adrenal insufficiency, fatty acid metabolism defect
  * **[MRI] High-signal lesion in brain**: Demyelination of CNS
  * **[Genetic test] ABCD1 mutation**
* **Management**
  * **Steroid hormone**: For adrenal insufficiency 
  * **No cure, dead in 1~5 years**
{: .notice--info}

## Peripheral Nerve Disorder / 末梢神経障害

## Muscular Disorder / 筋疾患

## Infectious Disorder / 感染性疾患

## Functional Disease / 機能性疾患

## Neurocutaneous Syndrome / 母斑症

## Brain Tumor / 脳腫瘍

## Head Injury / 頭部外傷

## Congenital Anomaly / 先天奇形

<!-- ## Cerebral Infarction / 脳梗塞

### Atherothrombotic Infarction / アテローム血栓性脳梗塞
### Cardioembolic Infarction / 心原性脳塞栓症
### Lacunar Infarction / ラクナ梗塞
### Transient Ischemic Attack / 一過性脳虚血発作
### Carotid Artery Stenosis / 頸動脈狭窄症
### Cerebellar Infarction / 小脳梗塞
### Wallenberg Syndrome / Wallenberg症候群

## Cerebral Hemorrhage / 脳出血

### Putaminal Hemorrhage / 被殻出血
### Thalamic Hemorrhage / 視床出血
### Brainstem Hemorrhage / 脳幹出血
### Cerebellar Hemorrhage / 小脳出血
### Subcortical Hemorrhage / 皮質下出血
### Subarachnoid Hemorrhage / くも膜下出血

## Other Cerebrovascular Disease / その他の脳血管疾患

### Cerebral Aneurysm / 脳動脈瘤
### Arteriovenous Malformation / 脳動静脈奇形
### Moyamoya Disease / もやもや病
### Carotid-Cavernous Fistula / 内頸動脈海綿静脈洞瘻
### Dural Arteriovenous Fistula / 硬膜動静脈瘻
### Sinus Thrombosis / 静脈洞血栓症
### Hypertensive Encephalopathy / 高血圧性脳症
### Spinal Arteriovenous Malformation / 脊髄動静脈奇形
### Spinal Cord Infarction / 脊髄梗塞

## Dementia / 認知症

### Alzheimer Type Dementia / Alzheimer型認知症
### Vascular Dementia / 血管性認知症
### Dementia with Lewy Bodies / Lewy小体型認知症
### Frontotemporal Lobar Degeneration / 前頭側頭葉変性症

## Neurodegenerative Disease / 神経変性疾患

### Parkinson's Disease / Parkinson病
### Progressive Supranuclear Palsy / 進行性核上性麻痺
### Corticobasal Degeneration / 大脳皮質基底核変性症
### Huntington's Disease / Huntington病
### MSA-C / MSA-C
### MSA-P / MSA-P
### Shy-Drager Syndrome / Shy-Drager症候群
### Cortical Cerebellar Atrophy / 皮質性小脳萎縮症
### SCA-3 / SCA-3
### SCA-6 / SCA-6
### Dentato-Rubro-Pallido-Luysian Atrophy / 歯状核赤核淡蒼球ルイ体萎縮症
### Friedreich Ataxia / Friedreich運動失調症
### Syringomyelia / 脊髄空洞症
### Subacute Combined Degeneration of Spinal Cord / 亜急性連合性脊髄変性症
### Amyotrophic Lateral Sclerosis / 筋萎縮性側索硬化症
### Spinal Muscular Atrophy / 脊髄性筋萎縮症
### Spinal and Bulbar Muscular Atrophy / 球脊髄性筋萎縮症

## Demyelinating Disease / 脱髄性疾患

### Multiple Sclerosis / 多発性硬化症
### Neuromyelitis Optica / 視神経脊髄炎
### Acute Disseminated Encephalomyelitis / 急性散在性脳脊髄炎
### Adrenoleukodystrophy / 副腎白質ジストロフィー
### Metachromatic Leukodystrophy / 異染性白質ジストロフィー

## Peripheral Neuropathy / 末梢神経障害

### Guillain-Barré Syndrome / Guillain-Barré症候群
### Chronic Inflammatory Demyelinating Polyneuropathy / 慢性炎症性脱髄性多発神経炎
### Charcot-Marie-Tooth Disease / Charcot-Marie-Tooth病
### Familial Amyloid Polyneuropathy / 家族性アミロイドポリニューロパチー
### Diabetic Neuropathy / 糖尿病性神経障害
### Wernicke Encephalopathy / Wernicke脳症
### Carcinomatous Neuropathy / 癌性ニュロパチー
### Crow-Fukase Syndrome / Crow-Fukase症候群
### Trigeminal Neuralgia / 三叉神経痛
### Bell's Palsy / Bell麻痺
### Ramsay Hunt Syndrome / Ramsay Hunt症候群

## Muscular Disease / 筋疾患

### Duchenne Muscular Dystrophy / Duchenne型筋ジストロフィー
### Becker Muscular Dystrophy / Becker型筋ジストロフィー
### Limb-Girdle Muscular Dystrophy / LG型筋ジストロフィー
### Fascioscapulohumeral Muscular Dystrophy / FSH型筋ジストロフィー
### Congenital Muscular Dystrophy / 先天性筋ジストロフィー
### Myotonic Dystrophy / 筋強直性ジストロフィー
### Mitochondrial Encephalomyopathy / ミトコンドリア脳筋症
### Periodic Paralysis / 周期性四肢麻痺
### Myasthenia Gravis / 重症筋無力症
### Lambert-Eaton Myasthenic Syndrome / Lambert-Eaton症候群

## Phacomatosis / 母斑症

### Neurofibromatosis Type 1 / 神経線維腫症１型
### Neurofibromatosis Type 2 / 神経線維腫症２型
### Tuberous Sclerosis / 結節性硬化症
### Von Hippel-Lindau Disease / Von Hippel-Lindau病
### Sturge-Weber Syndrome / Sturge-Weber症候群

## Infectious Disease / 感染性疾患

### Bacterial Meningitis / 細菌性髄膜炎
### Tuberculous Meningitis / 結核性髄膜炎
### Fungal Meningitis / 真菌性髄膜炎
### Viral Meningitis / ウイルス性髄膜炎
### Herpes Simplex Encephalitis / 単純ヘルペス脳炎症
### HIV-Associated Neurocognitive Disorder / HIV 関連神経認知障害
### HTLV-1 Associated Myelopathy / HTLV-1 関連脊髄症
### Subacute Sclerosing Panencephalitis / 亜急性硬化性全脳炎
### Progressive Multifocal Leukoencephalopathy / 進行性多巣性白質脳症
### Creutzfeldt-Jakob Disease / Creutzfeldt-Jakob病
### Brain Abscess / 脳膿瘍
### Neurosyphilis / 神経梅毒
### Acute Encephalopathy / 急性脳症
### Reye Syndrome / Reye症候群
### Acute Cerebellar Ataxia / 急性小脳失調症

## Brain Tumor / 脳腫瘍

### Diffuse Astrocytoma / びまん性星細胞腫
### Glioblastoma / 膠芽腫
### Oligodendroglioma / 乏突起膠腫
### Ependymoma / 上衣腫
### Medulloblastoma / 髄芽腫
### Meningioma / 髄膜腫
### Schwannoma / 神経鞘腫
### Pituitary Adenoma / 下垂体腺腫
### Craniopharyngioma / 頭蓋咽頭腫
### Germ Cell Tumor / 胚細胞腫瘍
### Hemangioblastoma / 血管芽腫
### Malignant Lymphoma / 悪性リンパ腫
### Metastatic Brain Tumor / 転移性脳腫瘍
### Spinal Cord Tumor / 脊髄腫瘍

## Functional Disease / 機能性疾患

### Rolandic Epilepsy / Rolandてんかん
### Temporal Lobe Epilepsy / 側頭葉てんかん
### Childhood Absence Epilepsy / 小児欠神てんかん
### Juvenile Myoclonic Epilepsy / 若年ミオクロニーてんかん
### West Syndrome / West症候群
### Lennox-Gastaut Syndrome / Lennox-Gastaut症候群
### Dravet Syndrome / Dravet症候群
### Febrile Seizure / 熱性けいれん
### Cerebral Palsy / 脳性麻痺
### Migraine / 片頭痛
### Tension-Type Headache / 緊張性頭痛
### Cluster Headache / 群発頭痛
### Restless Legs Syndrome / むずむず脚症候群

## Head Injury / 頭部外傷

### Skull Base Fracture / 頭蓋底骨折
### Cranial Vault Fracture / 円蓋部骨折
### Acute Epidural Hematoma / 急性硬膜外血腫
### Acute Subdural Hematoma / 急性硬膜下血腫
### Chronic Subdural Hematoma / 慢性硬膜下血腫
### Cerebral Contusion / 脳挫傷
### Diffuse Axonal Injury / びまん性軸索損傷
### Spinal Cord Injury / 脊髄損傷
### Normal Pressure Hydrocephalus / 正常圧水頭症 -->

# Psychiatry / 精神科

## Introduction / 総論

## Schizophrenia / 統合失調症

## Mood Disorder / 気分障害

## Neurotic Disorder / 神経症性障害

## Physiologic Disorder / 生理的障害

## Personality Disorder / 人格障害

## Developmental Disorder / 発達障害

## Organic Mental Disorder / 器質性精神障害

## Substance Related Disorder / 物質関連障害

# Ophthalmology / 眼科

## Introduction / 総論

## Functional Disorder / 機能障害

## Conjunctiva Disorder / 結膜疾患

## Cornea Disorder / 角膜疾患

## Uvea Disorder / ぶどう膜疾患

## Retina Disorder / 網膜疾患

## Cataract / 白内障

## Glaucoma / 緑内障

## Optic Nerve Disorder / 視神経疾患

## Eyelid and Lacrimal Apparatus Disorder / 眼瞼・涙器疾患

## Miscellaneous Ophthalmic Disorder / その他の眼科疾患

# Otolaryngology / 耳鼻咽喉科

## Introduction / 総論

## External and Middle Ear Disorder / 外耳・中耳疾患

## Inner Ear Disorder / 内耳疾患

## Nose and Paranasal Sinus Disorder / 鼻・副鼻腔疾患

## Oral Cavity and Tonsil Disorder / 口腔・扁桃疾患

## Pharynx and Larynx Disorder / 咽頭・喉頭疾患

## Cervical and Facial Disorder / 頸部・顔面疾患

<!-- ### Upper Respiratory Tract / 上気道 -->

<!-- * **Nose**
  * **Structure**: Palatine, nasal septum (medial), ethmoid, 3 nasal choncha
  * **Histology**: Pseudostratified columnar epithelium, olfactory mucosa (olfactory cell, subtentacular cell, basal cell)
  * **Artery**: Anterior and posterior ethmoidal artery (ophthalmic artery), inferior labial artery (facial artery), sphenopalatine artery (maxillary artery)
  * **Nerve**: Olfactory nerve (CN I), anterior ethmoidal nerve (CN V2), nasopalatine nerve (CN V3)
  * **Nasal meatus**: Sphenoethmoidal recess (sphenoid sinus), superior meatus (posterior ethmoid sinus), middle meatus (other paranasal sinus), inferior meatus (nasolacrimal duct)
  * **Paranasal sinus**: Frontal sinus, sphenoid sinus, ethmoid sinus, sphenoid sinus
* **Pharynx**
  * **Structure**: Nasopharynx (nasal cavity), oropharynx (oral cavity), laryngopharynx (trachea, esophagus)
  * **Histology**: Pseudostratified columnar (nasopharynx), stratified squamous (oropharynx, laryngopharynx)
  * **Nerve**: CN V2 (nasopharynx), CN IX (oropharynx), CN X (laryngopharynx)
* **Larynx**
  * **Structure**: Thyroid cartilage, cricoid cartilage (C6), arytenoid cartilage, vestibular fold, vocal fold
  * **Muscle**: Cricothyroideus (tense), lateral cricoarytenoideus (close), posterior cricoarytenoideus (open), thyroarytenoideus (relax), transverse arytenoideus (close), oblique arytenoideus (constrict), vocalis (control)
  * **Nerve**: External laryngeal nerve (CN X, cricothyroideus), internal laryngeal nerve (CN X, sensation above vocal fold), recurrent laryngeal nerve (CN X, other muscle, left loop aoric arch, right loop subclavian artery)
{: .notice--info} -->

# Dermatology / 皮膚科

## Introduction / 総論

## Eczema / 湿疹

## Urticaria / 蕁麻疹

## Erythema / 紅斑症

## Bullous Dermatoses / 水疱症

## Keratosis / 角化症

## Pigmentary Disorder / 色素異常症

## Nevus / 母斑

## Skin Tumor / 皮膚腫瘍

## Skin Infection / 皮膚感染症

## Epidermal Appendage Disorder / 皮膚附属器疾患

## Dermis Disorder / 真皮疾患

## Collagen Disease / 膠原病

## Metabolism Disorder / 代謝異常症

## Physical Disorder / 物理的障害


<!-- ## Eczema and Dermatitis / 湿疹・皮膚炎

### Contact Dermatitis /  接触皮膚炎
### Atopic Dermatitis / アトピー性皮膚炎
### Asteatotic Eczema / 皮脂欠乏性湿疹
### Seborrheic Dermatitis / 脂漏性皮膚炎
### Nummular Eczema / 貨幣状湿疹
### Autosensitization Dermatitis / 自家感作性皮膚炎
### Stasis Dermatitis / うっ滞性皮膚炎
### Lichen Vidal / Vidal苔癬
### Pompholyx / 汗疱

## Urticaria and Pruritis / 蕁麻疹・掻痒

### Urticaria / 蕁麻疹
### Angioedema / 血管性浮腫
### Prurigo / 痒疹
### Pruritus Cutaneous / 皮膚瘙痒症

## Erythema and Drug Eruption / 紅斑症・薬疹

### Erythema Exsudativum Multiforme / 多形滲出性紅斑
### Erythema Nodosum / 結節性紅斑
### Erythema Induratum / 硬結性紅斑
### Sweet's Disease / Sweet病
### Drug Eruption / 薬疹
### Fixed Drug Eruption / 固定薬疹
### Stevens-Johnson Syndrome / Stevens-Johnson症候群
### Toxic Epidermal Necrolysis / 中毒性表皮壊死症
### Drug-Induced Hypersensitivity Syndrome / 薬剤性過敏症症候群
### Skin Disorders Caused by Anticancer Drugs / 抗がん薬による皮膚障害
### Erythroderma / 紅皮症
### Graft-Versus-Host Disease / 移植片対宿主病

## Bullous Dermatoses and Pustulosis / 水疱症・膿疱症

### Pemphigus Vulgaris / 尋常性天疱瘡
### Pemphigus Foliaceus / 落葉状天疱瘡
### Bullous Pemphigoid / 水疱性類天疱瘡
### Dermatitis Herpetiformis Duhring / Duhring疱疹状皮膚炎
### Epidermolysis Bullosa Acquisita / 後天性表皮水疱症
### Epidermolysis Bullosa Hereditaria / 先天性表皮水疱症
### Palmoplantar Pustulosis / 掌蹠膿疱症

## Keratosis / 角化症

### Psoriasis Vulgaris / 尋常性乾癬
### Guttate Psoriasis / 滴状乾癬
### Pustular Psoriasis / 膿疱性乾癬
### Psoriatic Erythroderma / 乾癬性紅皮症
### Parapsoriasis En Plaques / 局面状類乾癬
### Pityriasis Lichenoides / 苔癬状粃糠疹
### Lichen Planus / 扁平苔癬
### Pityriasis Rosea Gibert / Gibertばら色粃糠疹
### Pityriasis Rubra Pilaris / 毛孔性紅色粃糠疹
### Keratosis Pilaris / 毛孔性角化症
### Clavus and Callus / 鶏眼・胼胝
### Acanthosis Nigricans / 黒色表皮腫
### Ichthyosis Vulgaris / 尋常性魚鱗癬
### X-Linked Ichthyosis / X連鎖性魚鱗癬
### Congenital Ichthyosiform Erythroderma / 先天性魚鱗癬様紅皮症
### Epidermolytic Ichthyosis / 表皮融解性魚鱗癬
### Palmoplantar Keratoderma / 掌蹠角化症
### Darier's Disease / Darier病

## Pigmentary Disorder / 色素異常症

### Oculocutaneous Albinism / 眼皮膚白皮症
### Vitiligo Vulgaris / 尋常性白斑
### Nevus Depigmentosus / 脱色素性母斑
### Vogt-Koyanagi-Harada Disease / Vogt-小柳-原田病
### Leucoderma Sutton / Sutton白斑
### Ephelides / 雀卵斑
### Melasma / 肝斑
### Senile Lentigo / 老人性色素斑

## Nevus / 母斑

### Epidermal Nevus / 表皮母斑
### Sebaceous Nevus / 脂腺母斑
### Melanocytic Nevus / 色素性母斑
### Spitz Nevus / Spitz母斑
### Nevus Spilus / 扁平母斑
### Nevus of Ota / 太田母斑
### Mongolian Spot / 蒙古斑
### Blue Nevus / 青色母斑

## Skin Tumor / 皮膚腫瘍

### Seborrheic Keratosis / 脂漏性角化症
### Porokeratosis / 汗孔角化症
### Epidermal Cyst / 表皮嚢腫
### Hypertrophic Scar and Keloid / 肥厚性瘢痕・ケロイド
### Mastocytoma / 肥満細胞症
### Infantile Hamangioma / 乳児血管腫
### Glomus Tumor / グロムス腫瘍
### Kasabach-Merritt Syndrome / Kasabach-Merritt症候群
### Capillary Malformation / 毛細血管奇形
### Basal Cell Carcinoma / 基底細胞癌
### Squamous Cell Carcinoma / 有棘細胞癌
### Keratoacanthoma / ケラトアカントーマ
### Solar Keratosis / 日光角化症
### Bowen's Disease / Bowen病
### Extramammary Paget's Disease / 乳房外Paget病
### Merkel Cell Carcinoma / Merkel細胞癌
### Malignant Melanoma / 悪性黒色腫
### Angiosarcoma / 血管肉腫
### Kaposi's Sarcoma / Kaposi肉腫
### Mycosis Fungoides / 菌状息肉症
### Sézary Syndrome / Sézary症候群

## Skin Infection / 皮膚感染症

### Folliculitis / 毛包炎
### Furuncle and Carbuncle / 癤・癰
### Paronychia / 爪囲炎
### Erysipelas / 丹毒
### Cellulitis / 蜂巣炎
### Necrotizing Fasciitis / 壊死性筋膜炎
### Gas Gangrene / ガス壊疽
### Impetigo Contagiosa / 伝染性膿痂疹
### Staphylococcal Scalded Skin Syndrome / ブドウ球菌性熱傷様皮膚症候群
### Toxic Shock Syndrome / トキシックショック症候群
### Scarlet Fever / 猩紅熱
### Tuberculosis Cutis / 皮膚結核
### Nontuberculous Mycobacteriosis / 非結核性抗酸菌症
### Leprosy / Hansen病
### Herpes Simplex / 単純疱疹
### Varicella / 水痘
### Herpes Zoster / 帯状疱疹
### Hand Foot and Mouth Disease / 手足口病
### Measles / 麻疹
### Rubella / 風疹
### Exanthema Subitum / 突発性発疹
### Erythema Infectiosum / 伝染性紅斑
### Gianotti Disease / Gianotti病
### Verruca Vulgaris / 尋常性疣贅
### Verruca Plana / 扁平疣贅
### Molluscum Contagiosum / 伝染性軟属腫
### Dermatophytosis / 白癬
### Cutaneous Candidiasis / 皮膚カンジダ症
### Malassezia Infection / マラセチア感染症
### Sporotrichosis / スポロトリコーシス
### Dematiaceous Fungal Infection / 黒色真菌症
### Scabies / 疥癬
### Pediculosis / シラミ症
### Lyme Disease / ライム病
### Scrub Typhus / ツツガムシ病 

## Epidermal Appendage Disease / 皮膚附属器の疾患

### Miliaria / 汗疹
### Hyperhidrosis / 多汗症
### Anhidrosis / 無汗症
### Bromidrosis / 臭汗症
### Acne Valgaris / 尋常性痤瘡
### Acneiform Eruption / 痤瘡様発疹
### Rosacea / 酒皶
### Rosacea-Like Dermatitis / 酒皶様皮膚炎
### Androgenetic Alopecia / 男性型脱毛症
### Alopecia Areata / 円形脱毛症
### Trichotillomania / 抜毛症
### Ingrown Nail / 陥入爪
-->

# Orthopedic Surgery / 整形外科

## Introduction / 総論

## Upper Limb Disorder / 上肢疾患

## Lower Limb Disorder / 下肢疾患

## Trunk Disorder / 体幹疾患

## Joint Disorder / 関節疾患

## Peripheral Nerve Disorder / 末梢神経疾患

## Trauma / 外傷

## Metabolic Disorder / 代謝性疾患

## Infectious Disorder / 感染性疾患

## Bone Tumor / 骨腫瘍

# Urology / 泌尿器科

## Introduction / 総論

## Urinary Tract Infection and Stone / 尿路感染症・結石

## Urinary Tract Tumor / 尿路腫瘍

## Urinary Tract Dysfunction / 尿路機能障害

## Urinary Tract Congenital Anomaly / 尿路先天異常

## Penis Disorder / 陰茎疾患

## Testicle Disorder / 睾丸疾患

## Prostate Disorder / 前立腺疾患


<!-- ### Male Genital Organ / 男性器

* **Scrotum**
  * **Structure**: Skin, smooth muscle (dartos)
  * **Artery**: Anterior scrotal artery (external pudendal artery), posterior scrotal artery (perineal artery)
  * **Nerve**: Scrotal nerve (perineal nerve)
  * **Spermatic cord**: Ductus deferens, tesicular artery, pampiniform plexus, genitofemoral nerve
* **Testis**
  * **Structure**: External fascia (external oblique), middle fascia (internal oblique), internal fascia (fascia transversalis), tunica vaginalis (peritoneum), tunica albuginea, lobule, seminoferous tube
  * **Artery**: Testicular artery (abdominal aorta)
  * **Vein**: Right testicular vein (inferior vena cava), left testicular vein (left renal vein)
  * **Spermatogenesis**: Spermatogonia, 1st spermatocyte, 2nd spermatocyte, spermatid, sperm
  * **Cell**: Sertoli cell (blood-testis barrier, activin, inhibin, MIF), Leydig cell (testosterone)
  * **Genital tracty**: Seminoferous tubule (spermatogenic cell, Sertoli cell), tubuli recti (Sertoli cell), rete testis (simple cuboidal), ductuli efferentes (simple columnar), epididymis (pseudostratified columnar, steriocelia), vas deferens (pseudostratified columnar, steriocelia)
* **Gland**
  * **Siminal vesicle**: Into prostate seminal coliculus
  * **Prostate**: Into prostatic sinus, central zone, peripheral zone (adenocarcinoma), transitional zone (BPH)
  * **Bulbourethral gland**: Into uretra
* **Penis**
  * **Structure**: 2 corpus cavernosa (crura, with tunica albuginea), 1 corpus spongisum (blub, glans)
  * **Artery**: Deep artery of penis (corpus cavernosa, perineal artery), artery of bulb (corpus spongiosum, perineal artery), dorsal artery of penis (glans, perineal artery)
  * **Nerve**: Dorsal nerve of penis (perineal nerve)
  * **Function**: Erection (parasympathetic, inferior hypogastric ganglion), ejaculation (sympathetic, superior hypogastric ganglion)
{: .notice--info} -->

<!-- ## Urinary Tract Dysfunction / 尿路機能障害

### Hydronephrosis / 水腎症
### Neurogenic Bladder / 神経因性膀胱
### Overactive Bladder / 過活動膀胱
### Stress Incontinence / 腹圧性尿失禁

## Urinary Tract and Genital Infection / 尿路・性器感染症

### Pyelonephritis / 腎盂腎炎
### Renal Abscess / 腎膿瘍
### Cystitis / 膀胱炎
### Urinary Tuberculosis / 尿路結核
### Urethritis / 尿道炎
### Prostatitis / 前立腺炎
### Epididymitis / 精巣上体炎
### Orchitis / 精巣炎

## Urinary Tract and Genital Tumor / 尿路・性器腫瘍

### Urinary Stone / 尿路結石
### Renal Cell Carcinoma / 腎細胞癌
### Renal Pelvic and Ureteral Cancer / 腎盂・尿管癌
### Bladder Cancer / 膀胱癌
### Penile Cancer / 陰茎癌
### Benign Prostatic Hyperplasia / 前立腺肥大症
### Prostatic Cancer / 前立腺癌
### Testicular Tumor / 精巣腫瘍

## Genital Dysfunction / 性器機能異常
### Varicocele / 精索静脈瘤
### Testicular Torsion / 精巣捻転症
### Phimosis / 包茎
### Erectile Dysfunction / 勃起障害
### Priapism / 持続勃起症
### Male Infertility / 男性不妊症 -->

# Gynecology / 婦人科

## Introduction / 総論

## Sexuel Development Disorder / 性分化疾患

## Endocrine Disorder / 内分泌の異常

## Aging-Related Disorder / 加齢による疾患

## Genital Infection / 性器感染症

## Valvar and Vaginal Disorder / 外陰・腟疾患

## Uterine Disorder / 子宮疾患

## Ovarian Disorder / 卵巣疾患

## Breast Disorder / 乳腺疾患

## Infertility / 不妊症

<!-- ## Endocrine Disorder / 内分泌の異常

### Anovulatory Cycle / 無排卵周期症

### Luteal Insufficiency / 黄体機能不全

### Premenstrual Syndrome / 月経前症候群

### Dysmenorrhea / 月経困難症

### Hyperprolactinemia / 高プロラクチン血症

### Anorexia Nervosa / 神経性やせ症

### Amenorrhea Due to Weight Loss / 単純性体重減少性無月経

### Sheehan Syndrome / Sheehan症候群

### Polycystic Ovary Syndrome / 多嚢胞性卵巣症候群

## Sex Development Disorder / 性分化疾患

### Congenital Adrenocortical Hyperplasia / 先天性副腎皮質過形成症

### Androgen Insensitivity Syndrome / アンドロゲン不応症

### Turner Syndrome / Turner症候群

### Klinefelter Syndrome / Klinefelter症候群 -->

# Obstetrics / 産科

## Introduction / 総論

## Early Pregnancy Disorder / 妊娠初期の異常

## Later Pregnancy Disorder / 妊娠中・後期の異常

## Complicated Pregnancy / 合併症妊娠

## Mother to Children Infection / 母子感染症

## Delivery Disorder / 分娩の異常

## Puerperium Disorder / 産褥の異常

# Pediatrics / 小児科

## Introduction / 総論

## Neonate Disorder / 新生児疾患

## Congenital Disorder / 先天異常

## Cardiovascular Disorder / 循環器疾患

## Respiratory Disorder / 呼吸器疾患

## Gastrointestinal Disorder / 消化器疾患

## Endocrine and Metabolism Disorder / 内分泌・代謝疾患

## Renal and Urologic Disorder / 腎・泌尿器疾患

## Hematologic Disorder / 血液疾患

## Immunologic Disorder / 免疫疾患

## Infectious Disorder / 感染性疾患

## Neurologic Disorder / 神経疾患

## Mental Disorder / 精神疾患

## Neoplasm / 新生物

<!-- ## Cardiovascular Disease / 循環器疾患

### Atrial Septal Defect / 心房中隔欠損症
### Ventricular Septal Defect / 心室中隔欠損症
### Atrioventricular Septal Defect / 房室中隔欠損症
### Patent Ductus Arteriosus / 動脈管開存症
### Coarctation of the Aorta / 大動脈縮窄症
### Eisenmenger Syndrome / Eisenmenger症候群
### Tetralogy of Fallot / Fallot四徴症
### Complete Transposition of Great Arteries / 完全大血管転位症
### Total Anomalous Pulmonary Venous Return / 総肺静脈還流異常症
### Double Outlet Right Ventricle / 両大血管右室起始症
### Hypoplastic Left Heart Syndrome / 左心低形成症候群
### Pulmonary Stenosis / 肺動脈狭窄症
### Pure Pulmonary Atresia / 純型肺動脈閉鎖
### Truncus Arteriosus Communis / 総動脈幹症
### Ruptured Aneurysm of the sinus of Valsalva / Valsalva洞動脈瘤破裂
### Tricuspid Atresia / 三尖弁閉鎖症
### Ebstein's Disease / Ebstein病
### Single Ventricle / 単心室症

## Gastrointestinal Disease / 消化器疾患

### Congenital Esophageal Atresia / 先天性食道閉鎖
### Hypertrophic Pyloric Stenosis / 肥厚性幽門狭窄症
### Congenital Duodenal Atresia or Stenosis / 先天性十二指腸閉鎖・狭窄症
### Congenital Intestinal Atresia or Stenosis / 先天性小腸閉鎖・狭窄症
### Intestinal Malrotation / 腸回転異常症
### Meckel Diverticulum / Meckel憩室
### Intussusception / 腸重積症
### Hirschsprung Disease / Hirschsprung病
### Necrotizing Enterocolitis / 壊死性腸炎
### Anal Atresia / 鎖肛 
### Bochdalek Hernia / Bochdalek孔ヘルニア
### Omphalocele / 臍帯ヘルニア
### Gastroschisis / 腹壁破裂
### Gilbert Syndrome / Gilbert症候群
### Crigler-Najjar Syndrome / Cirgler-Najjar症候群
### Dubin-Johnson Syndrome / Dubin-Johnson症候群
### Rotor Syndrome / Rotor症候群
### Biliary Atresia / 胆道閉鎖症
### Congenital Biliary Dilatation / 先天性胆道拡張症

## Metabolism Disease / 代謝疾患

### Phenylketonuria / フェニルケトン尿症
### Maple Syrup Urine Disease / メープルシロップ尿症
### Homocystinurea / ホモシスチン尿症
### Urea Cycle Defect / 尿素サイクル異常症
### Von Gierke Disease / Von Gierke病
### Pompe Disease / Pompe病
### Galactosemia / ガラクトース血症
### Lactose Intolerance / 乳糖不耐症
### Mucopolysaccharidoses / ムコ多糖症
### Tay-Sachs Disease / Tay-Sachs病
### Fabry Disease / Fabry病
### Gaucher Disease / Gaucher病
### Nieman-Pick Disease / Nieman-Pick病
### Lesch-Nyhan Syndrome / Lesch-Nyhan症候群
### Wilson's Disease / Wilson病
### Menkes Disease / Menkes病
### Marfan Syndrome / Marfan症候群
### Ehlers-Danlos Syndrome / Ehlers-Danlos症候群
### Ketotic Hypoglycemia / ケトン性低血糖症
### Acetonic Vomiting / アセトン血性嘔吐症
### Osteomalacia / 骨軟化症
### Osteogenesis Imperfecta / 骨形成不全症
### Chondrodysplasia / 軟骨異形成症

## Endocrine Disease / 内分泌疾患

### Growth Hormone Deficiency / 成長ホルモン欠乏症
### Congenital Hypothyroidism / 先天性甲状腺機能低下症
### Precocious Puberty / 早発性思春期
### McCune-Albright Syndrome / McCune-Albright症候群
### Turner Syndrome / Turner症候群
### Klinefelter Syndrome / Klinefelter症候群
### Kallman Syndrome / Kallman症候群
### Prader-Willi Syndrome / Prader-Willi症候群
### Congenital Adrenocortical Hyperplasia / 先天性副腎皮質過形成
### Androgen Insensitivity Syndrome / アンドロゲン不応症

## Renal and Urologic Disease / 腎・泌尿器疾患

### Polycystic Kidney Disease / 多発性嚢胞腎
### Sponge Kidney / 海綿腎
### Horseshoe Kidney / 馬蹄腎
### Congenital Hydronephrosis / 先天性水腎症
### Duplicated Renal Pelvis and Ureter / 重複腎孟尿管
### Ectopic Ureter / 尿管異所開口
### Ureterocele / 尿管瘤
### Vesicourethral Reflux / 膀胱尿管逆流
### Hypospadias / 尿道下裂
### Cryptorchidism / 停留精巣
### Hydrocele Testis / 陰嚢水腫

## Hematologic Disease / 血液疾患

### Hemophilia / 血友病
### Von Willebrand Disease / Von Willebrand病
### Bernard-Soulier Syndrome / Bernard-Soulier症候群
### Glanzmann Thrombasthenia / 血小板無力症

## Immune Disease / 免疫疾患

### Severe Combined Immunodeficiency / 重症複合免疫不全症
### X-linked Agammaglobulinemia / X連鎖無γ-グロブリン血症
### Hyper-IgM Syndrome / 高IgM症候群
### Wiskott-Aldrich Syndrome / Wiskott-Aldrich症候群
### Ataxia Telangiectasia / 毛細血管拡張性運動失調症
### DiGeorge Syndrome / DiGeorge症候群
### Chédiak-Higashi Syndrome / Chédiak-Higashi症候群
### Chronic Granulomatous Disease / 慢性肉芽腫症

## Neurological Disease / 神経疾患

### Craniosynostosis / 頭蓋縫合早期癒合症
### Spina Bifida / 二分脊椎
### Cranium Bifidum / 二分頭蓋
### Congenital Hydrocephalus / 先天性水頭症
### Chiari Malformation / Chiari奇形
### Dandy-Walker Syndrome / Dandy-Walker症候群
### Arachnoid Cyst / くも膜嚢胞

## Neoplasm / 新生物

### Hepatoblastoma / 肝芽腫
### Wilms' Tumor / Wilms腫瘍 -->

<!-- # Emergency Medicine / 救急科

## Shock / ショック

### Cardiopulmonary Arrest / 心肺停止
### Hypovolemic Shock / 循環血液量減少性ショック
### Anaphylactic Shock / アナフィラキシーショック
### Neurogenic Shock / 神経原性ショック
### Septic Shock / 敗血症性ショック
### Cardiogenic Shock / 心原性ショック
### Extracardiac Obstructive Shock / 心外閉塞性ショック

## Emergency Disease / 救急疾患

### Airway Foreign Body / 気道異物
### Gastrointestinal Foreign Body / 消化管異物
### Status Epilepticus / てんかん重積状態
### Acute Abdomen / 急性腹症
### Multiple Organ Dysfunction Syndrome / 多臓器不全

## Thoracic Injury / 胸部外傷

### Tracheobronchial Injury / 気管・気管支損傷
### Pulmonary Contusion / 肺挫傷
### Flail Chest / 胸郭動揺
### Open Pneumothorax / 開放性気胸
### Tension Pneumothorax / 緊張性気胸
### Aortic Injury / 大動脈損傷
### Massive Hemothorax / 大量血胸

## Abdominal Injury / 腹部外傷

### Liver Injury / 肝損傷
### Splenic Rupture / 脾破裂
### Kidney Injury / 腎外傷
### Urethral Injury / 尿道外傷
### Bladder Injury / 膀胱外傷
### Testicular Injury / 精巣外傷

## Other Injury / その他の外傷

### High Energy Trauma / 高エネルギー外傷
### Crush Syndrome / 圧挫症候群
### Compartment Syndrome / コンパートメント症候群
### Fat Embolism Syndrome / 脂肪塞栓症候群
### Burns / 熱傷
### Smoke Inhalation Injury / 気道熱傷

## Diseases due to Physical Factors / 物理的要因による疾患

### Heat Illness / 熱中症
### Accidental Hypothermia / 偶発性低体温症
### Altitude Sickness / 高山病
### Decompression Sickness / 減圧症

## Poisoning / 中毒

### Food Poisoning / 食中毒
### Drug Poisoning / 薬物中毒
### Organic Solvent Poisoning / 有機溶剤中毒
### Toxic Gas Poisoning / 有毒ガス中毒
### Metal Poisoning / 金属中毒
### Pesticide Poisoning / 農薬中毒 -->
